≡ Risteys
R14

Documentation Changelog GitHub Contact & Feedback

Generalized epilepsy, mode (most common among epilepsy diagnosis)

DOID EFO Endpoint Browser PheWeb

GE_MODE

Endpoint definition

↥

Report an error or suggest an improvement for this endpoint codes

Endpoint definition steps

FinnGen

Phenotype data

519870

1. Apply sex-specific rule

None

519870

2. Check conditions

None

519870

3. Check pre-conditions, main-only, mode, registry filters

Check mode of ICD-10 codes: %34519, %345[0-3], %G403

Registry filters:

  • Hospital discharge: ICD-10 — G40.3
  • Hospital discharge: ICD-9 — %345[0-3]
  • Hospital discharge: ICD-8 — %34519
  • Hospital discharge: excluded ICD-8 — 34511
  • Cause of death: ICD-10 — G40.3
  • Cause of death: ICD-9 — %345[0-3]
  • Cause of death: ICD-8 — %34519
  • Cause of death: excluded ICD-8 — 34511

2 out of 7 registries used, show all original rules.

1284

4. Check minimum number of events

None

1284

5. Include endpoints

None

1284

6. Filter based on genotype QC (FinnGen only)

1238

Control definitions (FinnGen only)

Control exclude
G6_EPLEPSY

Extra metadata

First used in FinnGen datafreeze
DF11

Case counts by codes

↥

FinnGen case counts by registry codes:

generic upset plot

Upset plot

Full data table

Summary Statistics

↥

-FinRegistry-

This endpoint is excluded (different definition than used in FinnGen).

-FinnGen-

Key figures

All Female Male
Number of individuals 1238 744 494
Unadjusted period prevalence (%) 0.25 0.26 0.23
Median age at first event (years) 26.63 23.71 31.01

-FinnGen-

Age distribution of first events

-FinnGen-

Year distribution of first events

-FinnGen-

Cumulative Incidence Function

CodeWAS

↥

CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.

This is a new tool, please reach out using the contact form for feedback and improvement ideas.

First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.

Matched cohort

Matched cases
1284
Matched controls
12840
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
183
Kela drug reimbursment
Lamotrigin and topiramate
+∞
307.7
311
*
R56.8
ICD-10 Finland
Other and unspecified convulsions
29.1
307.7
370
176
N03AF01
ATC
carbamazepine; oral, rectal
31.0
307.7
390
178
N03AX09
ATC
lamotrigine; oral
13.3
307.7
353
355
G40.39
ICD-10 Finland
Other or unspecified generalized epileptic syndromes with atonic, clonic, myoclonic or tonic-clonic seizures
+∞
307.7
572
*
111
Kela drug reimbursment
Epilepsy and comparable convulsive disorders
+∞
307.7
1089
*
182
Kela drug reimbursment
Brivaracetam, eslikarbazepin, gabapentin, lacosamide, levetiracetam, perampanel, pregabalin, tiagabin and zonisamide
4166.6
307.7
328
*
N03AG01
ATC
valproic acid; systemic, rectal
53.6
307.7
715
294
N03AX14
ATC
levetiracetam; systemic
151.3
307.7
336
30
3451A
ICD-9 Finland
Epilepsy, Generalised convulsive epilepsy
+∞
307.7
345
*
N03AF02
ATC
oxcarbazepine; oral
49.2
307.7
241
60
G40.9
ICD-10 Finland
Epilepsy, unspecified
2882.7
307.7
609
*
G40.3
ICD-10 Finland
Generalized idiopathic epilepsy and epileptic syndromes
+∞
272.9
252
*
G40.30
ICD-10 Finland
Benign myoclonic eplilepsy in infancy
+∞
246.0
228
*
G40
ICD-10 Finland
Epilepsy
1244.9
220.5
209
*
N05BA01
ATC
diazepam; systemic, rectal
6.6
192.6
384
775
N03AB02
ATC
phenytoin; systemic
78.2
188.3
101
14
G40.36
ICD-10 Finland
Juvenile myoclonic epilepsy [impulsive petit mal]
+∞
188.3
176
*
G40.29
ICD-10 Finland
Localization-related (focal)(partial) symptomatic epilepsy and epileptic syndromes with complex partial seizures
+∞
177.3
166
*
G40.22
ICD-10 Finland
Complex partial epileptic seizure with secondary generalization
+∞
170.7
160
*
7803A
ICD-9 Finland
General symptoms, Convulsions
24.6
167.8
121
54
N88
ICPC
Epilepsy
+∞
160.9
151
*
N03AE01
ATC
clonazepam; systemic
8.5
142.3
200
273
G40.20
ICD-10 Finland
Complex partial seizures with only alteration of consciousness
+∞
126.2
119
*
G40.2
ICD-10 Finland
Localization-related (focal)(partial) symptomatic epilepsy and epileptic syndromes with complex partial seizures
+∞
121.8
115
*
34519
ICD-8 Finland
Epilepsy, Generalisata convulsiva NUD
+∞
120.8
114
*
N05BA09
ATC
clobazam; oral
326.5
118.3
118
*
78020
ICD-8 Finland
Certain symptoms referable to nervous system and special senses, Convulsions
22.1
113.7
85
41
G40.6
ICD-10 Finland
Grand mal seizures, unspecified (with or without petit mal)
+∞
113.2
107
*
O99.3
ICD-10 Finland
Mental disorders and diseases of the nervous system complicating pregnancy, childbirth and the puerperium
10.9
102.2
114
114
3459X
ICD-9 Finland
Epilepsy, unspecified
+∞
96.1
91
*
34599
ICD-8 Finland
Epilepsy, Other and unspecified
+∞
93.9
89
*
G40.4
ICD-10 Finland
Other generalized epilepsy and epileptic syndromes
+∞
92.8
88
*
G40.89
ICD-10 Finland
Other epilepsy
+∞
87.5
83
*
N03AX11
ATC
topiramate; oral
8.3
82.2
113
148
3450A
ICD-9 Finland
Epilepsy, Generalised nonconvulsive epilepsy
+∞
82.2
78
*
G40.35
ICD-10 Finland
Juvenile absence epilepsy
+∞
76.8
73
*
3453A
ICD-9 Finland
Epilepsy, Grand mal status
+∞
75.8
72
*
G40.10
ICD-10 Finland
Simple partial seizures
+∞
71.5
68
*
34510
ICD-8 Finland
Epilepsy, """"Grand mal""""
+∞
64.1
61
*
N03AD01
ATC
ethosuximide; oral
+∞
64.1
61
*
N05CD08
ATC
midazolam; nasal, systemic
10.7
64.0
71
70
G40.33
ICD-10 Finland
Juvenile absence epilepsy
+∞
60.9
58
*
G40.09
ICD-10 Finland
Other or unspecified partial (focal) idiopathic epilepsy or epileptic syndrome with local onset
+∞
58.8
56
*
AA1AD
NOMESCO Finland
CT of head and brain
2.7
53.0
383
1748
G40.00
ICD-10 Finland
Benign childhood epilepsy with centrotemporal EEG spikes
+∞
52.5
50
*
N03AX18
ATC
lacosamide; systemic
528.5
51.8
51
*
3454A
ICD-9 Finland
Epilepsy, Partial epilepsy, with impairment of consciousness[EPILEPSIA GENERALISATA SECUNDARIA]
+∞
50.3
48
*
G40.12
ICD-10 Finland
Simple partial seizures with secondary generalization
+∞
48.2
46
*
G40.1
ICD-10 Finland
Localization-related (focal)(partial) symptomatic epilepsy and epileptic syndromes with simple partial seizures
+∞
47.2
45
*
G40.19
ICD-10 Finland
Localization-related (focal)(partial) symptomatic epilepsy and epileptic syndromes with simple partial seizures
431.3
42.4
42
*
G41.9
ICD-10 Finland
Status epilepticus, unspecified
77.8
40.2
45
6
N03AX22
ATC
perampanel; oral
+∞
37.7
36
*
N03AX23
ATC
brivaracetam; systemic
+∞
36.6
35
*
XA800
NOMESCO Finland
Neuropsychological investigation
3.9
32.6
100
271
Z03.3
ICD-10 Finland
Observation for suspected nervous system disorder
3.6
31.5
111
331
AA1CG
NOMESCO Finland
Extensive MRI examination of brain with high intensity magnet
3.0
30.9
148
533
34532
ICD-8 Finland
Epilepsy, Partialis (focalis) generalisata
+∞
30.3
29
*
AA1BG
NOMESCO Finland
Standard MRI examination of brain with high intensity magnet
2.7
28.1
162
643
112
Kela drug reimbursment
Severe psychotic and other severe mental disorders
3.0
28.1
134
480
AA1CM
NOMESCO Finland
Extensive MRI examination of brain with 3 Tesla magnet
6.1
27.4
48
81
GD1QA
NOMESCO Finland
Supine thorax X-ray examination
2.5
26.4
188
827
R29.8
ICD-10 Finland
Other and unspecified symptoms and signs involving the nervous and musculoskeletal systems
2.9
26.3
134
498
F02.89*G40.9
ICD-10 Finland
Dementia in epilepsy
+∞
26.1
25
*
J69.0
ICD-10 Finland
Pneumonitis due to food and vomit
7.4
25.5
37
51
G40.21
ICD-10 Finland
Partial epileptic seizure with cloudiness and automatism
+∞
25.1
24
*
N03AG04
ATC
vigabatrin; oral
+∞
25.1
24
*
N05AA02
ATC
levomepromazine; systemic
3.8
24.1
75
205
N03AX15
ATC
zonisamide; oral
57.2
24.1
28
5
E87.1
ICD-10 Finland
Hypo-osmolality and hyponatraemia
4.2
23.2
63
156
R55
ICD-10 Finland
Syncope and collapse
2.6
22.6
140
575
34500
ICD-8 Finland
Epilepsy, """"Petit mal""""
+∞
21.9
21
*
G40.0
ICD-10 Finland
Localization-related (focal)(partial) idiopathic epilepsy and epileptic syndromes with seizures of localized onset
+∞
21.9
21
*
N05AD01
ATC
haloperidol; systemic
4.6
21.9
53
120
AA1BM
NOMESCO Finland
MRI examination of brain with 3 Tesla magnet
7.0
21.7
33
48
Z00.4
ICD-10 Finland
General psychiatric examination, not elsewhere classified
2.2
20.0
192
956
N05AX08
ATC
risperidone; systemic
2.5
19.8
131
554
J18.9
ICD-10 Finland
Pneumonia, unspecified
1.9
19.4
305
1813
G40.7
ICD-10 Finland
Petit mal, unspecified, without grand mal seizures
+∞
18.8
18
*
34530
ICD-8 Finland
Epilepsy, Psychomotorica
+∞
18.8
18
*
R41.8
ICD-10 Finland
Other and unspecified symptoms and signs involving cognitive functions and awareness
2.6
18.4
110
443
WX700
NOMESCO Finland
Respiratory and circulatory monitoring
2.1
18.2
198
1032
XA400
NOMESCO Finland
EEG
16.8
17.9
28
17
W01
ICD-10 Finland
Fall on same level from slipping, tripping and stumbling
1.8
17.9
365
2342
G40.31
ICD-10 Finland
Benign neonatal convulsions (familial)
+∞
17.7
17
*
3454B
ICD-9 Finland
Epilepsy, Partial epilepsy, with impairment of consciousness[TEMPORAALIEPILEPTINEN POISSAOLOKOHTAUS]
+∞
17.7
17
*
181
Kela drug reimbursment
Retigabine and vigabatrin
+∞
17.7
17
*
34598
ICD-8 Finland
Epilepsy, Alia definita
+∞
17.7
17
*
G41.0
ICD-10 Finland
Grand mal status epilepticus
50.7
17.0
20
*
G40.37
ICD-10 Finland
Baltic myoclonus
+∞
16.7
16
*
R42
ICD-10 Finland
Dizziness and giddiness
1.9
16.6
266
1581
4380A
ICD-9 Finland
Late effects of cerebrovascular disease[SEQUELAE MORBI CEREBROVASCULARIS]
48.1
16.0
19
*
J15.9
ICD-10 Finland
Bacterial pneumonia, unspecified
2.4
15.9
110
475
3039X
ICD-9 Finland
Alcohol dependence syndrome, Other and unspecified alcohol dependence
6.5
15.9
26
41
G40.34
ICD-10 Finland
Epilepsy with grand mal seizures on awakening
+∞
15.7
15
*
N06AB04
ATC
citalopram; systemic
1.8
14.8
250
1505
W19
ICD-10 Finland
Unspecified fall
2.2
14.6
138
679
3452A
ICD-9 Finland
Epilepsy, Petit mal status
+∞
14.6
14
*
Z50.8
ICD-10 Finland
Care involving use of other rehabilitation procedures
2.4
14.6
101
436
N05AH03
ATC
olanzapine; systemic
2.3
14.5
111
501
F32.9
ICD-10 Finland
Depressive episode, unspecified
1.9
14.3
213
1233
F20.9
ICD-10 Finland
Schizophrenia, unspecified
3.7
14.2
45
125
Z2445
NOMESCO Finland
Psychologist
2.6
14.0
85
345
Y0209
ICD-8 Finland
Examination of the nervous system and sensory organs, Nervous system
16.0
13.9
22
14
N07
ICPC
Convulsion/seizure
24.1
13.8
19
8
TPH04
NOMESCO Finland
Cathetrisation of vein
1.8
13.7
251
1546
F44.5
ICD-10 Finland
Dissociative convulsions
+∞
13.6
13
*
G40.80
ICD-10 Finland
Epilepsy with continuous EEG spike-waves during slow wave sleep
+∞
13.6
13
*
T36
ICD-10 Finland
Poisoning by systemic antibiotics
2.6
13.2
76
300
F20.00
ICD-10 Finland
Paranoid schizophrenia continuous
3.7
13.1
41
113
N04AA02
ATC
biperiden; systemic
4.0
13.0
36
91
N05AH02
ATC
clozapine; systemic
3.6
12.8
41
115
N03AA02
ATC
phenobarbital; systemic
70.6
12.6
14
*
GD1UA
NOMESCO Finland
Thorax X-ray examination outside radiological department
1.9
12.6
170
951
I69.3
ICD-10 Finland
Sequelae of cerebral infarction
2.6
12.6
75
302
N05AH04
ATC
quetiapine; oral
1.7
12.3
256
1631
X69
ICD-10 Finland
Intentional self-poisoning by and exposure to other and unspecified chemicals and noxious substances
2.8
12.0
59
215
XF400
NOMESCO Finland
ECG with 12 standard connections
1.9
11.7
169
966
N05AC02
ATC
thioridazine; oral
3.7
11.6
36
99
G40.11
ICD-10 Finland
Simple partial epileptic seizure that develops into a complex partial seizure
+∞
11.5
11
*
3454X
ICD-9 Finland
Epilepsy, Partial epilepsy, with impairment of consciousness[ALII DISTURBATIONES CONSCIENTAE EPILEPTICI]
+∞
11.5
11
*
N05CD07
ATC
temazepam; oral
2.1
11.4
113
567
X59
ICD-10 Finland
Exposure to unspecified factor
1.7
11.2
245
1577
A06AD11
ATC
lactulose; oral
1.9
11.1
140
764
Z01.8
ICD-10 Finland
Other specified special examinations
1.7
11.1
265
1746
R56.0
ICD-10 Finland
Febrile convulsions
8.1
11.1
24
30
R53
ICD-10 Finland
Malaise and fatigue
1.6
11.1
327
2269
R11
ICD-10 Finland
Nausea and vomiting
2.0
10.6
126
675
P99
ICPC
Psychological disorders other
2.6
10.5
59
231
K07
ICPC
Swollen ankles/oedema
2.8
10.4
52
191
G40.8
ICD-10 Finland
Other epilepsy
+∞
10.4
10
*
N05AB03
ATC
perphenazine; systemic, rectal
2.8
10.3
50
181
A04
ICPC
Weakness/tiredness general
1.7
10.3
208
1311
F10.1
ICD-10 Finland
Mental and behavioural disorders due to use of alcohol, Harmful use
2.2
10.2
89
424
F29
ICD-10 Finland
Unspecified nonorganic psychosis
2.4
10.1
69
297
7819X
ICD-9 Finland
Symptoms involving nervous and musculoskeletal systems, Other symptoms involving nervous and musculoskeletal systems[SYMPTOMATA ALIA SYSTEMATIS NERVORUM ET MUSCULOSCEL]
9.2
10.0
20
22
GD1AA
NOMESCO Finland
Thorax X-ray examination
1.5
9.9
474
3637
GD1PA
NOMESCO Finland
X-ray examination of the lungs in one projection
2.0
9.9
109
569
I63.9
ICD-10 Finland
Cerebral infarction, unspecified
2.1
9.6
87
421
SPAT1240
SPAT
Therapeutic discussion
1.8
9.5
163
979
6489X
ICD-9 Finland
Other current conditions in the mother classifiable elsewhere but complicating pregnancy, childbirth and the puerperium, Other current conditions classifiable elsewhere
15.2
9.5
15
10
4859X
ICD-9 Finland
Bronchopneumonia, organism unspecified[PNEUMONIA NUD]
3.4
9.5
34
103
N01
ICPC
Headache
1.7
9.5
199
1265
G41.2
ICD-10 Finland
Complex partial status epilepticus
100.8
9.4
10
*
3458X
ICD-9 Finland
Epilepsy, Other forms of epilepsy
+∞
9.4
9
*
34539
ICD-8 Finland
Epilepsy, Partialis (focalis) NUD
+∞
9.4
9
*
ADB00
NOMESCO Finland
Implantation of vagus nerve stimulating device
+∞
9.4
9
*
7802X
ICD-9 Finland
General symptoms, Syncope and collapse[SYNCOPE ET COLLAPSUS NUD]
12.4
9.4
16
13
F32.2
ICD-10 Finland
Severe depressive episode without psychotic symptoms
2.0
9.1
105
556
E950A
ICD-9 Finland
Suicide and self-inflicted poisoning by solid or liquid substances
5.1
9.1
19
38
N05BA04
ATC
oxazepam; oral
1.5
8.9
297
2107
TAB00
NOMESCO Finland
Lumbar puncture
2.3
8.7
63
278
R10.4
ICD-10 Finland
Other and unspecified abdominal pain
1.4
8.6
456
3546
A46
ICD-10 Finland
Erysipelas
1.8
8.4
141
842
R51.80
ICD-10 Finland
Headache
1.6
8.4
220
1476
N03AG06
ATC
tiagabine; oral
+∞
8.3
8
*
R40.2
ICD-10 Finland
Coma, unspecified
8.6
8.3
17
20
Z50.9
ICD-10 Finland
Care involving use of rehabilitation procedure, unspecified
2.5
8.2
52
216
N05CF01
ATC
zopiclone; oral
1.5
8.2
319
2331
P76
ICPC
Depressive disorder
1.9
8.2
112
628
S06.0
ICD-10 Finland
Concussion
1.7
8.2
143
864
78259
ICD-8 Finland
Symptoms referable to cardiovascular and lymphatic system, Syncope (lipothymia) alia sive NUD
33.6
8.1
10
*
C03CA01
ATC
furosemide; systemic
1.6
8.0
229
1565
4300A
ICD-9 Finland
Subarachnoid haemorrhage[HAEMORRHAGIA SUBARACHNOID. POST ANEURYSMA SACCULARE]
22.2
8.0
11
5
SPAT1301
SPAT
No procedures
1.5
7.9
337
2505
A10AB01
ATC
insulin (human); parenteral
2.4
7.9
52
220
G25.0
ICD-10 Finland
Essential tremor
3.1
7.9
32
105
P72
ICPC
Schizophrenia
2.9
7.8
35
122
R25.2
ICD-10 Finland
Cramp and spasm
3.0
7.7
33
112
V700A
ICD-9 Finland
General medical examination, Routine general medical examination at a health care facility
3.0
7.7
32
107
WX892
NOMESCO Finland
Monitored bed care
2.0
7.6
84
438
E8859
ICD-8 Finland
Fall on same level from slipping, stumbling or tripping
2.9
7.6
34
118
113
Kela drug reimbursment
Anxiety disorders associated with mental retardation
25.2
7.6
10
*
30188
ICD-8 Finland
Personality disorders, Alia definita
10.1
7.5
14
14
N05AF03
ATC
chlorprothixene; systemic
2.8
7.5
37
136
R60.9
ICD-10 Finland
Oedema, unspecified
2.2
7.5
59
271
NH3BA
NOMESCO Finland
Foot and toes extensive X-ray examination
2.6
7.5
43
171
2402
FHL
External neurolysis of the nerve and possible alteration of the pathway (nerve pressure)
3.9
7.4
21
54
J46
ICD-10 Finland
Status asthmaticus
2.7
7.4
38
143
V628A
ICD-9 Finland
Other psychosocial circumstances, Other psychological or physical stress, not elsewhere classified
+∞
7.3
7
*
G41.1
ICD-10 Finland
Petit mal status epilepticus
+∞
7.3
7
*
G40.59
ICD-10 Finland
Other special epileptic syndromes
+∞
7.3
7
*
F33.30
ICD-10 Finland
Recurrent depression, severe episode without somatic syndrome
4.2
7.3
19
46
F60.3
ICD-10 Finland
Emotionally unstable personality disorder
3.3
7.3
27
84
F41.09
ICD-10 Finland
UNS Panic Syndrome
2.3
7.2
52
230
79199
ICD-8 Finland
Headache
4.5
7.2
17
38
S70.0
ICD-10 Finland
Contusion of hip
2.5
7.1
44
181
A28
ICPC
Limited function/disability NOS
1.7
7.1
139
865
Z2446
NOMESCO Finland
Social worker
1.9
7.0
93
518
F99
ICD-10 Finland
Mental disorder, not otherwise specified
2.7
6.9
37
142
SPAT1222
SPAT
Counselling/guidance promoting independent living
1.7
6.9
131
810
R2130
NOMESCO Finland
Counselling and guidance which enhance independent living
1.8
6.9
99
565
N02AE01
ATC
buprenorphine; parenteral, sublingual, transdermal
1.7
6.8
113
672
J01DA01
ATC
[U] cefalexin
1.4
6.8
692
5933
L28
ICPC
Limited function/disability (L)
1.6
6.8
162
1062
N05AF05
ATC
zuclopenthixol; systemic
4.3
6.8
17
40
31099
ICD-8 Finland
Borderline mental retardation, Other and unspecified
40.3
6.8
8
*
R1230
NOMESCO Finland
Neuropsychological evaluation of need and possibilities to rehabilitation
3.4
6.7
23
68
G43.0
ICD-10 Finland
Migraine without aura [common migraine]
1.8
6.7
102
592
R4160
NOMESCO Finland
Other therapy enhancing rehabilitation
2.7
6.7
35
133
2152
FHL
Extraction, big brain
22.6
6.7
9
*
F60.31
ICD-10 Finland
Emotionally unstable personality disorder, borderline condition
2.9
6.7
30
105
79399
ICD-8 Finland
Observation, without need for further medical care, Unspecified
5.5
6.6
18
33
IAZ97
NOMESCO Finland
Psychiatric consultation in another specialty
2.8
6.5
31
112
I26.9
ICD-10 Finland
Pulmonary embolism without mention of acute cor pulmonale
2.2
6.4
51
235
85000
ICD-8 Finland
Concussion, Current or unspecified
3.0
6.4
27
91
78159
ICD-8 Finland
Other symptoms referable to nervous system and special senses, Laesio loquendi alia sive NUD
14.4
6.4
10
7
30300
ICD-8 Finland
Alcoholism, Episodic excessive drinking
8.2
6.3
13
16
N29
ICPC
Neurological sympt/complt other
3.1
6.3
25
81
NH3AA
NOMESCO Finland
Foot and toes X-ray examination
1.7
6.3
103
610
F70.1
ICD-10 Finland
Mild mental retardation, Significant impairment of behaviour requiring attention or treatment
11.1
6.3
11
10
29599
ICD-8 Finland
Schizophrenia, Unspecified type
11.1
6.3
11
10
NA3AD
NOMESCO Finland
Lumbar spine and sacrum CT examination
3.0
6.3
27
92
34520
ICD-8 Finland
Epilepsy, Status epilepticus
+∞
6.3
6
*
N03AF04
ATC
eslicarbazepine; oral
+∞
6.3
6
*
G40.51
ICD-10 Finland
Epileptic seizures related to alcohol
+∞
6.3
6
*
31599
ICD-8 Finland
Unspecified mental retardation, Other and unspecified
+∞
6.3
6
*
S42.2
ICD-10 Finland
Fracture of upper end of humerus
2.3
6.2
46
206
4340A
ICD-9 Finland
Occlusion of cerebral arteries, Cerebral thrombosis
7.1
6.2
14
20
S60.2
ICD-10 Finland
Contusion of other parts of wrist and hand
1.9
6.2
75
405
S93.4
ICD-10 Finland
Sprain and strain of ankle
1.6
6.2
166
1118
D01
ICPC
Abdominal pain/cramps general
1.6
6.1
165
1111
N10
ICD-10 Finland
Acute tubulo-interstitial nephritis
1.6
6.1
127
803
78050
ICD-8 Finland
Certain symptoms referable to nervous system and special senses, Vertigo
7.7
6.1
13
17
E9509
ICD-8 Finland
Suicide and self-inflicted poisoning by solid or liquid substances, Other and unspecified solid and liquid substances
7.7
6.1
13
17
F32.10
ICD-10 Finland
Moderate depressive episode without somatic syndrome
1.6
6.1
126
797
M01AE03
ATC
ketoprofen; systemic, rectal
1.4
6.0
341
2650
P29
ICPC
Psychological sympt/compl other
1.6
6.0
128
814
9694A
ICD-9 Finland
Poisoning by psychotropic agents, Benzodiazepine-based tranquillisers
6.7
6.0
14
21
J01EA01
ATC
trimethoprim; systemic
1.4
6.0
261
1936
S01.0
ICD-10 Finland
Open wound of scalp
1.9
6.0
78
431
N05AB04
ATC
prochlorperazine; systemic, rectal
3.3
6.0
22
68
E883A
ICD-9 Finland
Fall into hole or other opening in surface
2.2
6.0
49
229

TimeCodeWAS

↥

TODO / Current known limitations:

  • Only showing the top 300 codes, because showing all (sometimes 20k) makes the page too slow.
  • Legend / how to read the glyphs.
  • Show details (e.g. Fisher or Chi-square test, LR+, etc.) when clicking on a row.
  • Explanation on the underlying data / how the TimeCodeWAS is done (e.g. matched cases / controls, eligibility).
  • Download CSV.
  • No filters and sorters.
  • Limited amount of endpoints (~400) having TimeCodeWAS data.
  • Cross-links to Risteys lab test pages for lab test codes.
OMOP concept
ln(OR)
%cases with code / %controls with code
2×2 table
valproic acid; oral, parenteral, rectal
N03AG01 [21604422]
4.6e+00
5.4e+00
—
1.0e+50
—
6.8e+00
5.6e+00
cases:16.41%
controls:0.20%
cases:20.96%
controls:0.12%
—
—
cases:9.13%
controls:0.00%
—
—
cases:39.52%
controls:0.07%
cases:44.03%
controls:0.29%
163
19
830
9707
209
12
788
9748
—
91
0
906
9760
—
392
7
600
9730
424
27
539
9435
Neurology
13 [38004458]
2.0e+00
3.3e+00
3.6e+00
1.0e+50
4.2e+00
3.9e+00
3.2e+00
cases:16.62%
controls:2.61%
cases:24.17%
controls:1.20%
cases:7.72%
controls:0.23%
cases:58.58%
controls:0.00%
cases:10.74%
controls:0.17%
cases:41.33%
controls:1.43%
cases:53.89%
controls:4.45%
165
254
828
9472
241
117
756
9643
77
22
920
9738
584
0
413
9760
107
17
889
9741
410
139
582
9598
519
421
444
9041
lamotrigine; oral
N03AX09 [21604431]
3.5e+00
3.9e+00
—
—
—
4.7e+00
3.9e+00
cases:3.52%
controls:0.11%
cases:3.81%
controls:0.08%
—
—
—
—
—
—
cases:9.07%
controls:0.09%
cases:13.08%
controls:0.30%
35
11
958
9715
38
8
959
9752
—
—
—
90
9
902
9728
126
28
837
9434
diazepam; oral, parenteral, rectal
N05BA01 [21604566]
2.2e+00
2.7e+00
3.1e+00
1.0e+50
3.2e+00
2.5e+00
2.3e+00
cases:6.14%
controls:0.75%
cases:6.12%
controls:0.45%
cases:2.01%
controls:0.09%
cases:0.80%
controls:0.00%
cases:2.61%
controls:0.11%
cases:5.24%
controls:0.45%
cases:12.25%
controls:1.34%
61
73
932
9653
61
44
936
9716
20
9
977
9751
8
0
989
9760
26
11
970
9747
52
44
940
9693
118
127
845
9335
Other and unspecified convulsions
R56.8 [45602033]
3.6e+00
5.1e+00
—
1.0e+50
—
3.4e+00
2.4e+00
cases:6.65%
controls:0.19%
cases:13.24%
controls:0.09%
—
—
cases:2.31%
controls:0.00%
—
—
cases:3.23%
controls:0.11%
cases:3.43%
controls:0.32%
66
18
927
9708
132
9
865
9751
—
23
0
974
9760
—
32
11
960
9726
33
30
930
9432
Paediatric neurology
421 [44777781]
7.1e-01
1.6e+00
2.7e+00
—
3.8e+00
2.8e+00
2.5e+00
cases:3.63%
controls:1.81%
cases:5.02%
controls:1.10%
cases:2.31%
controls:0.16%
—
—
cases:5.42%
controls:0.13%
cases:12.40%
controls:0.84%
cases:13.08%
controls:1.22%
36
176
957
9550
50
107
947
9653
23
16
974
9744
—
54
13
942
9745
123
82
869
9655
126
115
837
9347
clonazepam; oral, parenteral
N03AE01 [21604415]
2.8e+00
2.7e+00
2.6e+00
—
—
3.0e+00
2.8e+00
cases:3.52%
controls:0.23%
cases:2.51%
controls:0.17%
cases:0.70%
controls:0.05%
—
—
—
—
cases:3.33%
controls:0.16%
cases:5.92%
controls:0.37%
35
22
958
9704
25
17
972
9743
7
5
990
9755
—
—
33
16
959
9721
57
35
906
9427
carbamazepine; oral, rectal
N03AF01 [21604417]
3.9e+00
5.0e+00
1.0e+50
1.0e+50
—
—
4.3e+00
cases:8.16%
controls:0.17%
cases:9.33%
controls:0.07%
cases:2.11%
controls:0.00%
cases:0.60%
controls:0.00%
—
—
—
—
cases:15.78%
controls:0.25%
81
17
912
9709
93
7
904
9753
21
0
976
9760
6
0
991
9760
—
—
152
24
811
9438
Inpatient Hospital
21 [8717]
2.7e-01
8.7e-01
1.6e+00
5.6e+00
1.7e+00
8.6e-01
6.5e-01
cases:27.79%
controls:22.70%
cases:16.85%
controls:7.80%
cases:5.62%
controls:1.20%
cases:14.34%
controls:0.06%
cases:5.82%
controls:1.14%
cases:18.15%
controls:8.54%
cases:41.12%
controls:26.71%
276
2208
717
7518
168
761
829
8999
56
117
941
9643
143
6
854
9754
58
111
938
9647
180
832
812
8905
396
2527
567
6935
Outpatient Visit
OP [9202]
3.0e-01
6.1e-01
7.5e-01
5.7e+00
1.3e+00
1.2e+00
1.1e+00
cases:47.83%
controls:40.36%
cases:40.42%
controls:26.91%
cases:13.44%
controls:6.81%
cases:51.96%
controls:0.35%
cases:20.18%
controls:6.74%
cases:57.06%
controls:28.06%
cases:76.53%
controls:51.90%
475
3925
518
5801
403
2626
594
7134
134
665
863
9095
518
34
479
9726
201
658
795
9100
566
2732
426
7005
737
4911
226
4551
Psychiatry
26 [38004469]
1.1e+00
1.4e+00
1.1e+00
3.2e+00
1.4e+00
1.3e+00
1.2e+00
cases:7.65%
controls:2.65%
cases:5.82%
controls:1.51%
cases:1.81%
controls:0.59%
cases:1.81%
controls:0.07%
cases:2.31%
controls:0.55%
cases:5.85%
controls:1.66%
cases:13.40%
controls:4.63%
76
258
917
9468
58
147
939
9613
18
58
979
9702
18
7
979
9753
23
54
973
9704
58
162
934
9575
129
438
834
9024
oxcarbazepine; oral
N03AF02 [21604418]
4.0e+00
—
—
1.0e+50
—
—
5.2e+00
cases:4.23%
controls:0.08%
—
—
—
—
cases:0.70%
controls:0.00%
—
—
—
—
cases:9.97%
controls:0.06%
42
8
951
9718
—
—
7
0
990
9760
—
—
96
6
867
9456
Creatine kinase [Enzymatic activity/volume] in Serum or Plasma
2157-6 [3007220]
6.1e-01
2.4e+00
2.4e+00
1.0e+50
—
1.8e+00
1.4e+00
cases:1.41%
controls:0.77%
cases:4.21%
controls:0.40%
cases:0.80%
controls:0.07%
cases:0.90%
controls:0.00%
—
—
cases:1.61%
controls:0.27%
cases:4.47%
controls:1.13%
14
75
979
9651
42
39
955
9721
8
7
989
9753
9
0
988
9760
—
16
26
976
9711
43
107
920
9355
Case Management Agency
251B00000X [38004193]
5.9e-01
6.6e-01
1.2e+00
3.0e+00
1.3e+00
5.9e-01
5.0e-01
cases:37.36%
controls:24.85%
cases:31.49%
controls:19.25%
cases:20.46%
controls:7.15%
cases:7.82%
controls:0.42%
cases:22.79%
controls:7.49%
cases:32.56%
controls:21.15%
cases:47.35%
controls:35.28%
371
2417
622
7309
314
1879
683
7881
204
698
793
9062
78
41
919
9719
227
731
769
9027
323
2059
669
7678
456
3338
507
6124
Pharmacy visit
OMOP4822462 [581458]
1.6e-01
5.6e-01
6.4e-01
2.9e+00
1.3e+00
1.2e+00
1.2e+00
cases:68.48%
controls:65.03%
cases:67.50%
controls:54.18%
cases:32.30%
controls:20.17%
cases:14.24%
controls:0.89%
cases:47.39%
controls:20.31%
cases:82.16%
controls:57.66%
cases:95.12%
controls:85.80%
680
6325
313
3401
673
5288
324
4472
322
1969
675
7791
142
87
855
9673
472
1982
524
7776
815
5614
177
4123
916
8118
47
1344
Erythrocyte [DistWidth] in Red Blood Cells
30385-9 [3002385]
-1.7e-01
4.4e-01
1.3e+00
3.3e+00
1.5e+00
7.7e-01
3.8e-01
cases:5.44%
controls:6.38%
cases:7.52%
controls:5.00%
cases:3.51%
controls:0.94%
cases:2.11%
controls:0.08%
cases:4.42%
controls:1.06%
cases:9.38%
controls:4.59%
cases:14.43%
controls:10.35%
54
621
939
9105
75
488
922
9272
35
92
962
9668
21
8
976
9752
44
103
952
9655
93
447
899
9290
139
979
824
8483
olanzapine; oral, parenteral
N05AH03 [21604543]
9.0e-01
1.8e+00
—
—
2.6e+00
1.7e+00
1.5e+00
cases:0.81%
controls:0.33%
cases:1.20%
controls:0.20%
—
—
—
—
cases:0.70%
controls:0.05%
cases:1.21%
controls:0.23%
cases:2.08%
controls:0.47%
8
32
985
9694
12
20
985
9740
—
—
7
5
989
9753
12
22
980
9715
20
44
943
9418
Inpatient Visit
IP [9201]
5.3e-01
1.1e+00
1.7e+00
—
2.3e+00
1.2e+00
7.3e-01
cases:19.23%
controls:12.30%
cases:9.33%
controls:3.46%
cases:2.21%
controls:0.40%
—
—
cases:2.91%
controls:0.31%
cases:8.17%
controls:2.52%
cases:9.45%
controls:4.78%
191
1196
802
8530
93
338
904
9422
22
39
975
9721
—
29
30
967
9728
81
245
911
9492
91
452
872
9010
Observation for suspected nervous system disorder
Z03.3 [45609903]
—
2.6e+00
—
—
—
2.8e+00
2.1e+00
—
—
cases:1.10%
controls:0.08%
—
—
—
—
—
—
cases:1.01%
controls:0.06%
cases:1.87%
controls:0.24%
—
11
8
986
9752
—
—
—
10
6
982
9731
18
23
945
9439
Extensive MRI examination of brain with high intensity magnet
AA1CG [2001300116]
9.7e-01
2.4e+00
—
—
—
3.1e+00
1.6e+00
cases:1.11%
controls:0.42%
cases:1.10%
controls:0.10%
—
—
—
—
—
—
cases:1.41%
controls:0.06%
cases:1.25%
controls:0.24%
11
41
982
9685
11
10
986
9750
—
—
—
14
6
978
9731
12
23
951
9439
Platelets [#/volume] in Blood
26515-7 [3007461]
7.5e-02
4.2e-01
1.0e+00
3.6e+00
1.3e+00
6.2e-01
2.4e-01
cases:8.86%
controls:8.28%
cases:9.73%
controls:6.63%
cases:3.91%
controls:1.42%
cases:2.81%
controls:0.08%
cases:5.02%
controls:1.48%
cases:11.90%
controls:6.79%
cases:18.80%
controls:15.37%
88
805
905
8921
97
647
900
9113
39
139
958
9621
28
8
969
9752
50
144
946
9614
118
661
874
9076
181
1454
782
8008
MCV [Entitic mean volume] in Red Blood Cells
30428-7 [3024731]
7.1e-02
4.1e-01
1.0e+00
3.6e+00
1.2e+00
6.1e-01
2.4e-01
cases:8.86%
controls:8.31%
cases:9.73%
controls:6.69%
cases:3.91%
controls:1.42%
cases:2.81%
controls:0.08%
cases:5.02%
controls:1.50%
cases:11.90%
controls:6.81%
cases:18.80%
controls:15.44%
88
808
905
8918
97
653
900
9107
39
139
958
9621
28
8
969
9752
50
146
946
9612
118
663
874
9074
181
1461
782
8001
MCH [Entitic mass]
28539-5 [3035941]
7.1e-02
4.1e-01
1.0e+00
3.6e+00
1.2e+00
6.1e-01
2.4e-01
cases:8.86%
controls:8.31%
cases:9.73%
controls:6.69%
cases:3.91%
controls:1.42%
cases:2.81%
controls:0.08%
cases:5.02%
controls:1.50%
cases:11.90%
controls:6.81%
cases:18.80%
controls:15.41%
88
808
905
8918
97
653
900
9107
39
139
958
9621
28
8
969
9752
50
146
946
9612
118
663
874
9074
181
1458
782
8004
Erythrocytes [#/volume] in Blood
26453-1 [3026361]
7.1e-02
4.1e-01
1.0e+00
3.6e+00
1.2e+00
6.1e-01
2.4e-01
cases:8.86%
controls:8.31%
cases:9.73%
controls:6.69%
cases:3.91%
controls:1.42%
cases:2.81%
controls:0.08%
cases:5.02%
controls:1.50%
cases:11.90%
controls:6.81%
cases:18.80%
controls:15.45%
88
808
905
8918
97
653
900
9107
39
139
958
9621
28
8
969
9752
50
146
946
9612
118
663
874
9074
181
1462
782
8000
Hematocrit [Volume Fraction] of Blood by calculation
20570-8 [3009542]
7.1e-02
4.1e-01
1.0e+00
3.6e+00
1.2e+00
6.1e-01
2.4e-01
cases:8.86%
controls:8.31%
cases:9.73%
controls:6.69%
cases:3.91%
controls:1.42%
cases:2.81%
controls:0.08%
cases:5.02%
controls:1.50%
cases:11.90%
controls:6.81%
cases:18.80%
controls:15.43%
88
808
905
8918
97
653
900
9107
39
139
958
9621
28
8
969
9752
50
146
946
9612
118
663
874
9074
181
1460
782
8002
Leukocytes [#/volume] in Blood
26464-8 [3010813]
6.8e-02
4.1e-01
1.0e+00
3.6e+00
1.3e+00
6.1e-01
2.4e-01
cases:8.86%
controls:8.33%
cases:9.73%
controls:6.70%
cases:3.91%
controls:1.43%
cases:2.81%
controls:0.08%
cases:5.02%
controls:1.49%
cases:11.90%
controls:6.81%
cases:18.90%
controls:15.45%
88
810
905
8916
97
654
900
9106
39
140
958
9620
28
8
969
9752
50
145
946
9613
118
663
874
9074
182
1462
781
8000
Hemoglobin [Mass/volume] in Blood
718-7 [3000963]
6.5e-02
4.1e-01
1.0e+00
3.6e+00
1.2e+00
6.1e-01
2.3e-01
cases:8.86%
controls:8.35%
cases:9.73%
controls:6.70%
cases:3.91%
controls:1.43%
cases:2.81%
controls:0.08%
cases:5.02%
controls:1.50%
cases:11.90%
controls:6.81%
cases:18.80%
controls:15.49%
88
812
905
8914
97
654
900
9106
39
140
958
9620
28
8
969
9752
50
146
946
9612
118
663
874
9074
181
1466
782
7996
Emergency Room Visit
ER [9203]
4.0e-01
1.3e+00
2.1e+00
—
1.7e+00
8.1e-01
5.6e-01
cases:23.77%
controls:17.32%
cases:20.46%
controls:6.74%
cases:6.42%
controls:0.85%
—
—
cases:3.41%
controls:0.67%
cases:13.31%
controls:6.41%
cases:34.06%
controls:22.71%
236
1685
757
8041
204
658
793
9102
64
83
933
9677
—
34
65
962
9693
132
624
860
9113
328
2149
635
7313
MCHC [Entitic Mass/volume] in Red Blood Cells
28540-3 [3003338]
4.4e-02
4.0e-01
1.2e+00
3.5e+00
1.4e+00
6.4e-01
1.3e-01
cases:7.25%
controls:6.96%
cases:8.02%
controls:5.54%
cases:3.31%
controls:1.07%
cases:2.41%
controls:0.07%
cases:4.52%
controls:1.13%
cases:9.58%
controls:5.29%
cases:13.91%
controls:12.39%
72
677
921
9049
80
541
917
9219
33
104
964
9656
24
7
973
9753
45
110
951
9648
95
515
897
9222
134
1172
829
8290
Child and Adolescent Psychiatry
OMOP4821986 [45756756]
6.9e-01
9.4e-01
1.4e+00
—
1.6e+00
1.2e+00
9.3e-01
cases:4.13%
controls:2.11%
cases:2.71%
controls:1.08%
cases:1.81%
controls:0.47%
—
—
cases:1.91%
controls:0.39%
cases:3.53%
controls:1.10%
cases:5.50%
controls:2.25%
41
205
952
9521
27
105
970
9655
18
46
979
9714
—
19
38
977
9720
35
107
957
9630
53
213
910
9249
levomepromazine; oral, parenteral
N05AA02 [21604493]
2.2e+00
2.5e+00
—
—
—
—
1.8e+00
cases:0.91%
controls:0.10%
cases:0.60%
controls:0.05%
—
—
—
—
—
—
—
—
cases:1.56%
controls:0.26%
9
10
984
9716
6
5
991
9755
—
—
—
—
15
25
948
9437
Syncope and collapse
R55 [45568141]
9.9e-01
3.5e+00
—
—
—
1.7e+00
1.3e+00
cases:0.91%
controls:0.34%
cases:1.91%
controls:0.06%
—
—
—
—
—
—
cases:0.81%
controls:0.15%
cases:1.45%
controls:0.40%
9
33
984
9693
19
6
978
9754
—
—
—
8
15
984
9722
14
38
949
9424
General Practice
1 [38004446]
3.7e-01
9.7e-01
1.8e+00
—
1.5e+00
1.2e+00
8.6e-01
cases:6.24%
controls:4.38%
cases:4.71%
controls:1.83%
cases:1.20%
controls:0.20%
—
—
cases:1.20%
controls:0.27%
cases:6.15%
controls:1.94%
cases:13.91%
controls:6.38%
62
426
931
9300
47
179
950
9581
12
20
985
9740
—
12
26
984
9732
61
189
931
9548
134
604
829
8858
oxazepam; oral
N05BA04 [21604569]
1.1e+00
1.4e+00
1.6e+00
—
1.4e+00
1.1e+00
9.8e-01
cases:3.42%
controls:1.13%
cases:2.71%
controls:0.68%
cases:1.00%
controls:0.19%
—
—
cases:0.90%
controls:0.22%
cases:2.62%
controls:0.87%
cases:6.65%
controls:2.60%
34
110
959
9616
27
66
970
9694
10
19
987
9741
—
9
21
987
9737
26
85
966
9652
64
246
899
9216
Neurosurgery
14 [38004459]
1.5e+00
1.7e+00
—
1.0e+50
—
2.0e+00
1.1e+00
cases:2.62%
controls:0.62%
cases:1.60%
controls:0.31%
—
—
cases:0.60%
controls:0.00%
—
—
cases:1.71%
controls:0.25%
cases:2.18%
controls:0.73%
26
60
967
9666
16
30
981
9730
—
6
0
991
9760
—
17
24
975
9713
21
69
942
9393
Pediatric Medicine
37 [38004477]
-2.6e-01
4.3e-02
6.1e-01
4.7e+00
8.0e-01
2.1e-01
3.8e-01
cases:11.38%
controls:14.29%
cases:7.92%
controls:7.61%
cases:3.61%
controls:2.00%
cases:7.12%
controls:0.07%
cases:4.22%
controls:1.95%
cases:7.96%
controls:6.56%
cases:11.63%
controls:8.23%
113
1390
880
8336
79
743
918
9017
36
195
961
9565
71
7
926
9753
42
190
954
9568
79
639
913
9098
112
779
851
8683
topiramate; oral
N03AX11 [21604433]
9.9e-01
—
—
—
—
2.8e+00
3.0e+00
cases:0.60%
controls:0.23%
—
—
—
—
—
—
—
—
cases:1.81%
controls:0.11%
cases:3.43%
controls:0.17%
6
22
987
9704
—
—
—
—
18
11
974
9726
33
16
930
9446
Supplier / Service Provider
OMOP5117446 [33004]
-1.6e+00
-1.6e+00
—
—
2.8e+00
3.0e+00
3.1e+00
cases:6.65%
controls:25.77%
cases:2.51%
controls:10.98%
—
—
—
—
cases:0.80%
controls:0.05%
cases:3.23%
controls:0.16%
cases:9.24%
controls:0.45%
66
2506
927
7220
25
1072
972
8688
—
—
8
5
988
9753
32
16
960
9721
89
43
874
9419
temazepam; oral
N05CD07 [21604642]
6.4e-01
1.2e+00
2.0e+00
—
—
1.3e+00
1.2e+00
cases:1.41%
controls:0.75%
cases:1.60%
controls:0.48%
cases:0.60%
controls:0.08%
—
—
—
—
cases:2.12%
controls:0.59%
cases:4.78%
controls:1.54%
14
73
979
9653
16
47
981
9713
6
8
991
9752
—
—
21
57
971
9680
46
146
917
9316
clozapine; oral, parenteral
N05AH02 [21604542]
—
—
—
—
—
3.2e+00
2.5e+00
—
—
—
—
—
—
—
—
—
—
cases:1.21%
controls:0.05%
cases:1.14%
controls:0.10%
—
—
—
—
—
12
5
980
9732
11
9
952
9453
midazolam; nasal, oral, parenteral, sublingual
N05CD08 [21604643]
—
—
—
—
—
2.8e+00
2.9e+00
—
—
—
—
—
—
—
—
—
—
cases:0.81%
controls:0.05%
cases:2.18%
controls:0.13%
—
—
—
—
—
8
5
984
9732
21
12
942
9450
Other and unspecified symptoms and signs involving cognitive functions and awareness
R41.8 [45534452]
—
2.1e+00
—
—
—
2.0e+00
1.4e+00
—
—
cases:0.80%
controls:0.10%
—
—
—
—
—
—
cases:0.91%
controls:0.12%
cases:1.14%
controls:0.29%
—
8
10
989
9750
—
—
—
9
12
983
9725
11
27
952
9435
pregabalin; oral
N02BF02 [955152]
9.7e-01
1.1e+00
1.5e+00
—
1.9e+00
1.2e+00
1.3e+00
cases:1.71%
controls:0.66%
cases:1.10%
controls:0.36%
cases:0.60%
controls:0.13%
—
—
cases:0.70%
controls:0.10%
cases:1.31%
controls:0.40%
cases:4.05%
controls:1.18%
17
64
976
9662
11
35
986
9725
6
13
991
9747
—
7
10
989
9748
13
39
979
9698
39
112
924
9350
C reactive protein [Mass/volume] in Serum or Plasma
1988-5 [3020460]
1.5e-01
6.6e-01
1.2e+00
3.3e+00
6.5e-01
4.2e-01
2.9e-01
cases:7.25%
controls:6.31%
cases:7.92%
controls:4.26%
cases:2.81%
controls:0.85%
cases:1.60%
controls:0.06%
cases:1.71%
controls:0.90%
cases:6.15%
controls:4.11%
cases:14.43%
controls:11.23%
72
614
921
9112
79
416
918
9344
28
83
969
9677
16
6
981
9754
17
88
979
9670
61
400
931
9337
139
1063
824
8399
Severe psychotic and other severe mental disorders
112 [2001600112]
1.5e+00
2.1e+00
—
—
—
1.5e+00
1.5e+00
cases:1.81%
controls:0.42%
cases:1.00%
controls:0.12%
—
—
—
—
—
—
cases:0.60%
controls:0.13%
cases:1.56%
controls:0.34%
18
41
975
9685
10
12
987
9748
—
—
—
6
13
986
9724
15
32
948
9430
Internal Medicine
11 [38004456]
6.1e-01
9.6e-01
1.2e+00
—
1.1e+00
6.3e-01
5.1e-01
cases:17.82%
controls:10.55%
cases:13.44%
controls:5.60%
cases:3.41%
controls:1.08%
—
—
cases:3.11%
controls:1.07%
cases:10.89%
controls:6.09%
cases:24.40%
controls:16.17%
177
1026
816
8700
134
547
863
9213
34
105
963
9655
—
31
104
965
9654
108
593
884
9144
235
1530
728
7932
Laboratory Visit
OMOP4822461 [32036]
3.9e-03
1.8e-01
9.6e-01
3.0e+00
1.0e+00
3.1e-01
8.3e-02
cases:10.07%
controls:10.03%
cases:11.23%
controls:9.52%
cases:6.82%
controls:2.72%
cases:3.21%
controls:0.16%
cases:7.23%
controls:2.79%
cases:13.61%
controls:10.32%
cases:20.35%
controls:19.03%
100
976
893
8750
112
929
885
8831
68
265
929
9495
32
16
965
9744
72
272
924
9486
135
1005
857
8732
196
1801
767
7661
risperidone; oral, parenteral
N05AX08 [21604559]
1.6e+00
2.0e+00
2.3e+00
—
—
1.2e+00
1.2e+00
cases:1.31%
controls:0.27%
cases:1.10%
controls:0.15%
cases:0.50%
controls:0.05%
—
—
—
—
cases:0.91%
controls:0.27%
cases:1.97%
controls:0.58%
13
26
980
9700
11
15
986
9745
5
5
992
9755
—
—
9
26
983
9711
19
55
944
9407
Calcium.ionized [Moles/volume] in Serum or Plasma
1995-0 [3021347]
-4.0e-02
1.1e+00
1.7e+00
—
1.2e+00
1.0e+00
8.9e-01
cases:2.11%
controls:2.20%
cases:4.61%
controls:1.53%
cases:1.81%
controls:0.33%
—
—
cases:1.10%
controls:0.34%
cases:3.02%
controls:1.09%
cases:5.61%
controls:2.39%
21
214
972
9512
46
149
951
9611
18
32
979
9728
—
11
33
985
9725
30
106
962
9631
54
226
909
9236
Sodium [Moles/volume] in Serum or Plasma
2951-2 [3019550]
8.6e-02
8.1e-01
1.4e+00
—
1.5e+00
6.5e-01
4.3e-01
cases:6.14%
controls:5.67%
cases:8.73%
controls:4.08%
cases:3.61%
controls:0.92%
—
—
cases:3.31%
controls:0.79%
cases:7.66%
controls:4.16%
cases:14.75%
controls:10.09%
61
551
932
9175
87
398
910
9362
36
90
961
9670
—
33
77
963
9681
76
405
916
9332
142
955
821
8507
Unspecified nonorganic psychosis
F29 [45533099]
1.4e+00
1.9e+00
—
—
—
1.7e+00
1.4e+00
cases:1.01%
controls:0.26%
cases:0.70%
controls:0.10%
—
—
—
—
—
—
cases:0.71%
controls:0.13%
cases:1.35%
controls:0.33%
10
25
983
9701
7
10
990
9750
—
—
—
7
13
985
9724
13
31
950
9431
Glucose [Moles/volume] in Serum or Plasma
14749-6 [3013826]
3.6e-01
1.2e+00
1.8e+00
—
1.0e+00
8.9e-01
6.7e-01
cases:3.42%
controls:2.42%
cases:5.02%
controls:1.51%
cases:1.40%
controls:0.25%
—
—
cases:0.80%
controls:0.30%
cases:2.92%
controls:1.22%
cases:6.96%
controls:3.68%
34
235
959
9491
50
147
947
9613
14
24
983
9736
—
8
29
988
9729
29
119
963
9618
67
348
896
9114
Valproate [Moles/volume] in Serum or Plasma
14946-8 [3009466]
—
—
—
—
1.0e+50
—
4.5e+00
—
—
—
—
—
—
—
—
cases:1.51%
controls:0.00%
—
—
cases:6.33%
controls:0.07%
—
—
—
—
15
0
981
9758
—
61
7
902
9455
Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma
19072-8 [3016431]
2.9e-02
1.1e+00
1.6e+00
—
1.1e+00
1.0e+00
8.0e-01
cases:2.32%
controls:2.25%
cases:4.61%
controls:1.62%
cases:1.60%
controls:0.34%
—
—
cases:1.10%
controls:0.36%
cases:3.13%
controls:1.17%
cases:5.92%
controls:2.74%
23
219
970
9507
46
158
951
9602
16
33
981
9727
—
11
35
985
9723
31
114
961
9623
57
259
906
9203
Obstetrics / Gynecology
16 [38004461]
1.8e-01
7.0e-02
2.8e-01
4.0e+00
3.5e-01
1.0e-01
4.5e-01
cases:13.09%
controls:11.18%
cases:5.02%
controls:4.69%
cases:1.10%
controls:0.84%
cases:2.61%
controls:0.05%
cases:1.20%
controls:0.85%
cases:5.85%
controls:5.32%
cases:22.01%
controls:15.24%
130
1087
863
8639
50
458
947
9302
11
82
986
9678
26
5
971
9755
12
83
984
9675
58
518
934
9219
212
1442
751
8020
Office Visit
OMOP4822458 [581477]
2.4e-01
6.8e-01
1.3e+00
—
1.3e+00
6.1e-01
5.3e-01
cases:7.65%
controls:6.14%
cases:4.81%
controls:2.49%
cases:1.10%
controls:0.30%
—
—
cases:1.41%
controls:0.40%
cases:4.64%
controls:2.58%
cases:11.42%
controls:7.08%
76
597
917
9129
48
243
949
9517
11
29
986
9731
—
14
39
982
9719
46
251
946
9486
110
670
853
8792
Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma
1742-6 [3006923]
1.8e-01
4.9e-01
1.0e+00
—
1.6e+00
7.8e-01
4.5e-01
cases:6.75%
controls:5.68%
cases:6.62%
controls:4.18%
cases:2.41%
controls:0.88%
—
—
cases:4.32%
controls:0.87%
cases:9.17%
controls:4.42%
cases:16.41%
controls:11.08%
67
552
926
9174
66
408
931
9352
24
86
973
9674
—
43
85
953
9673
91
430
901
9307
158
1048
805
8414
Moderate panic disorder
F41.00 [2000501994]
2.1e+00
—
—
—
—
—
2.2e+00
cases:0.60%
controls:0.07%
—
—
—
—
—
—
—
—
—
—
cases:1.04%
controls:0.12%
6
7
987
9719
—
—
—
—
—
10
11
953
9451
Psychologist
Z2445 [2001311558]
9.2e-01
1.3e+00
—
—
—
1.9e+00
2.4e+00
cases:1.21%
controls:0.48%
cases:0.90%
controls:0.26%
—
—
—
—
—
—
cases:0.91%
controls:0.13%
cases:2.28%
controls:0.21%
12
47
981
9679
9
25
988
9735
—
—
—
9
13
983
9724
22
20
941
9442
Potassium [Moles/volume] in Serum or Plasma
2823-3 [3023103]
8.2e-02
8.0e-01
1.2e+00
—
1.3e+00
5.2e-01
3.8e-01
cases:6.14%
controls:5.69%
cases:8.63%
controls:4.08%
cases:3.01%
controls:0.91%
—
—
cases:2.81%
controls:0.81%
cases:6.75%
controls:4.12%
cases:14.23%
controls:10.17%
61
553
932
9173
86
398
911
9362
30
89
967
9671
—
28
79
968
9679
67
401
925
9336
137
962
826
8500
Standard MRI examination of brain with high intensity magnet
AA1BG [2001300112]
9.0e-01
2.6e+00
—
1.0e+50
—
1.9e+00
1.6e+00
cases:1.01%
controls:0.41%
cases:1.10%
controls:0.08%
—
—
cases:0.70%
controls:0.00%
—
—
cases:0.60%
controls:0.09%
cases:1.35%
controls:0.29%
10
40
983
9686
11
8
986
9752
—
7
0
990
9760
—
6
9
986
9728
13
27
950
9435
Intentional self-poisoning by and exposure to other and unspecified chemicals and noxious substances
X69 [45585661]
1.6e+00
—
—
—
—
—
2.4e+00
cases:1.01%
controls:0.20%
—
—
—
—
—
—
—
—
—
—
cases:1.56%
controls:0.15%
10
19
983
9707
—
—
—
—
—
15
14
948
9448
Anxiety disorder, unspecified
F41.9 [45542849]
1.1e+00
1.6e+00
—
—
—
1.3e+00
1.2e+00
cases:1.51%
controls:0.49%
cases:1.10%
controls:0.22%
—
—
—
—
—
—
cases:1.11%
controls:0.32%
cases:3.12%
controls:0.96%
15
48
978
9678
11
21
986
9739
—
—
—
11
31
981
9706
30
91
933
9371
Social worker
Z2446 [2001311559]
6.2e-01
1.2e+00
—
—
—
2.1e+00
1.7e+00
cases:1.31%
controls:0.71%
cases:0.60%
controls:0.18%
—
—
—
—
—
—
cases:0.91%
controls:0.11%
cases:1.66%
controls:0.30%
13
69
980
9657
6
18
991
9742
—
—
—
9
11
983
9726
16
28
947
9434
Poisoning by systemic antibiotics
T36 [45756588]
1.4e+00
1.7e+00
—
—
—
—
2.4e+00
cases:1.01%
controls:0.25%
cases:0.60%
controls:0.11%
—
—
—
—
—
—
—
—
cases:1.87%
controls:0.18%
10
24
983
9702
6
11
991
9749
—
—
—
—
18
17
945
9445
CBC panel - Blood by Automated count
58410-2 [40761511]
9.0e-02
4.9e-01
1.3e+00
—
1.3e+00
7.2e-01
2.6e-01
cases:7.45%
controls:6.86%
cases:7.12%
controls:4.49%
cases:2.81%
controls:0.81%
—
—
cases:2.71%
controls:0.78%
cases:7.96%
controls:4.06%
cases:14.43%
controls:11.50%
74
667
919
9059
71
438
926
9322
28
79
969
9681
—
27
76
969
9682
79
395
913
9342
139
1088
824
8374
Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma
1805-1 [3016417]
—
—
—
—
—
2.2e+00
1.5e+00
—
—
—
—
—
—
—
—
—
—
cases:1.11%
controls:0.12%
cases:1.87%
controls:0.42%
—
—
—
—
—
11
12
981
9725
18
40
945
9422
Mental disorders and diseases of the nervous system complicating pregnancy, childbirth and the puerperium
O99.3 [45606675]
—
—
—
—
—
—
3.7e+00
—
—
—
—
—
—
—
—
—
—
—
—
cases:2.49%
controls:0.06%
—
—
—
—
—
—
24
6
939
9456
Hospital outpatient
ZY010 [2001311599]
8.1e-01
1.3e+00
1.9e+00
—
—
1.8e+00
1.8e+00
cases:1.01%
controls:0.45%
cases:0.70%
controls:0.19%
cases:0.50%
controls:0.07%
—
—
—
—
cases:0.91%
controls:0.15%
cases:1.77%
controls:0.31%
10
44
983
9682
7
19
990
9741
5
7
992
9753
—
—
9
15
983
9722
17
29
946
9433
Medical doctor
Z2221 [2001311556]
5.2e-01
1.0e+00
9.5e-01
—
1.5e+00
1.2e+00
1.3e+00
cases:3.32%
controls:2.00%
cases:2.21%
controls:0.79%
cases:0.50%
controls:0.19%
—
—
cases:0.50%
controls:0.11%
cases:2.52%
controls:0.78%
cases:6.75%
controls:1.96%
33
195
960
9531
22
77
975
9683
5
19
992
9741
—
5
11
991
9747
25
76
967
9661
65
185
898
9277
Methadone [Presence] in Urine by Screen method
19550-3 [3028707]
1.0e+00
2.0e+00
—
—
—
—
1.5e+00
cases:0.60%
controls:0.22%
cases:0.60%
controls:0.08%
—
—
—
—
—
—
—
—
cases:1.04%
controls:0.23%
6
21
987
9705
6
8
991
9752
—
—
—
—
10
22
953
9440
Oxygen [Partial pressure] in Venous blood
2705-2 [3024354]
—
3.5e-01
1.7e+00
—
1.8e+00
4.0e-01
8.2e-01
—
—
cases:1.10%
controls:0.78%
cases:0.80%
controls:0.15%
—
—
cases:0.70%
controls:0.11%
cases:0.81%
controls:0.54%
cases:1.87%
controls:0.83%
—
11
76
986
9684
8
15
989
9745
—
7
11
989
9747
8
53
984
9684
18
79
945
9383
General symptoms, Convulsions
7803A [2000406893]
3.4e+00
1.0e+50
1.0e+50
—
1.0e+50
—
—
cases:2.22%
controls:0.07%
cases:2.71%
controls:0.00%
cases:0.80%
controls:0.00%
—
—
cases:0.60%
controls:0.00%
—
—
—
—
22
7
971
9719
27
0
970
9760
8
0
989
9760
—
6
0
990
9758
—
—
Emergency Medicine
93 [38004510]
-2.2e-01
1.1e+00
1.9e+00
—
5.2e-01
5.9e-01
4.6e-01
cases:2.01%
controls:2.50%
cases:5.12%
controls:1.83%
cases:1.50%
controls:0.23%
—
—
cases:0.60%
controls:0.36%
cases:3.33%
controls:1.88%
cases:9.45%
controls:6.20%
20
243
973
9483
51
179
946
9581
15
22
982
9738
—
6
35
990
9723
33
183
959
9554
91
587
872
8875
propranolol; oral, parenteral
C07AA05 [21601670]
3.7e-01
5.8e-01
—
—
2.4e+00
9.8e-01
3.1e-01
cases:2.32%
controls:1.61%
cases:1.50%
controls:0.85%
—
—
—
—
cases:0.90%
controls:0.08%
cases:2.32%
controls:0.88%
cases:3.43%
controls:2.55%
23
157
970
9569
15
83
982
9677
—
—
9
8
987
9750
23
86
969
9651
33
241
930
9221
Care involving use of other rehabilitation procedures
Z50.8 [45556842]
1.2e+00
—
—
—
—
3.3e+00
1.1e+00
cases:0.70%
controls:0.22%
—
—
—
—
—
—
—
—
cases:1.41%
controls:0.05%
cases:1.25%
controls:0.43%
7
21
986
9705
—
—
—
—
14
5
978
9732
12
41
951
9421
Migraine without aura [common migraine]
G43.0 [45600784]
4.7e-01
1.4e+00
—
—
—
1.8e+00
6.7e-01
cases:0.81%
controls:0.50%
cases:1.20%
controls:0.29%
—
—
—
—
—
—
cases:0.81%
controls:0.13%
cases:1.66%
controls:0.86%
8
49
985
9677
12
28
985
9732
—
—
—
8
13
984
9724
16
81
947
9381
quetiapine; oral
N05AH04 [21604544]
1.3e+00
8.7e-01
1.2e+00
—
1.1e+00
9.5e-01
1.0e+00
cases:3.02%
controls:0.88%
cases:1.50%
controls:0.64%
cases:0.70%
controls:0.20%
—
—
cases:0.50%
controls:0.16%
cases:1.71%
controls:0.67%
cases:4.67%
controls:1.70%
30
86
963
9640
15
62
982
9698
7
20
990
9740
—
5
16
991
9742
17
65
975
9672
45
161
918
9301
mirtazapine; oral
N06AX11 [21604740]
8.1e-01
1.5e+00
—
—
—
8.8e-01
5.5e-01
cases:2.92%
controls:1.33%
cases:2.91%
controls:0.68%
—
—
—
—
—
—
cases:1.92%
controls:0.80%
cases:4.57%
controls:2.69%
29
129
964
9597
29
66
968
9694
—
—
—
19
78
973
9659
44
255
919
9207
Respiratory and circulatory monitoring
WX700 [2001310817]
3.7e-01
1.8e+00
—
—
—
1.5e+00
1.3e+00
cases:0.91%
controls:0.63%
cases:1.00%
controls:0.16%
—
—
—
—
—
—
cases:0.50%
controls:0.11%
cases:2.49%
controls:0.69%
9
61
984
9665
10
16
987
9744
—
—
—
5
11
987
9726
24
65
939
9397
Outpatient Hospital
22 [8756]
1.9e-01
7.1e-01
1.1e+00
—
8.5e-01
7.3e-01
6.2e-01
cases:16.01%
controls:13.66%
cases:8.73%
controls:4.50%
cases:1.81%
controls:0.64%
—
—
cases:1.41%
controls:0.60%
cases:9.38%
controls:4.74%
cases:27.73%
controls:17.05%
159
1329
834
8397
87
439
910
9321
18
62
979
9698
—
14
59
982
9699
93
462
899
9275
267
1613
696
7849
zolpidem; oral
N05CF02 [21604655]
6.3e-01
8.6e-01
—
—
1.9e+00
1.0e+00
6.9e-01
cases:1.61%
controls:0.86%
cases:1.10%
controls:0.47%
—
—
—
—
cases:0.70%
controls:0.10%
cases:1.51%
controls:0.55%
cases:2.39%
controls:1.22%
16
84
977
9642
11
46
986
9714
—
—
7
10
989
9748
15
54
977
9683
23
115
940
9347
Other specified special examinations
Z01.8 [45581003]
7.1e-01
2.2e-01
2.8e+00
—
1.9e+00
8.5e-01
6.4e-01
cases:2.11%
controls:1.05%
cases:0.70%
controls:0.56%
cases:1.00%
controls:0.06%
—
—
cases:0.50%
controls:0.07%
cases:1.01%
controls:0.43%
cases:2.60%
controls:1.38%
21
102
972
9624
7
55
990
9705
10
6
987
9754
—
5
7
991
9751
10
42
982
9695
25
131
938
9331
Troponin I.cardiac [Mass/volume] in Serum or Plasma
10839-9 [3021337]
8.5e-01
1.3e+00
—
—
—
1.5e+00
1.2e+00
cases:1.01%
controls:0.43%
cases:0.90%
controls:0.24%
—
—
—
—
—
—
cases:1.01%
controls:0.22%
cases:2.49%
controls:0.74%
10
42
983
9684
9
23
988
9737
—
—
—
10
21
982
9716
24
70
939
9392
FEV1/FVC
19926-5 [3011505]
1.4e+00
—
—
—
—
1.3e+00
1.3e+00
cases:1.51%
controls:0.36%
—
—
—
—
—
—
—
—
cases:0.60%
controls:0.16%
cases:1.66%
controls:0.45%
15
35
978
9691
—
—
—
—
6
16
986
9721
16
43
947
9419
FEV1
20150-9 [3024653]
1.4e+00
—
—
—
—
1.3e+00
1.3e+00
cases:1.51%
controls:0.36%
—
—
—
—
—
—
—
—
cases:0.60%
controls:0.16%
cases:1.66%
controls:0.45%
15
35
978
9691
—
—
—
—
6
16
986
9721
16
43
947
9419
Forced vital capacity [Volume] Respiratory system
19870-5 [3020158]
1.4e+00
—
—
—
—
1.3e+00
1.3e+00
cases:1.51%
controls:0.36%
—
—
—
—
—
—
—
—
cases:0.60%
controls:0.16%
cases:1.66%
controls:0.45%
15
35
978
9691
—
—
—
—
6
16
986
9721
16
43
947
9419
biperiden; oral, parenteral
N04AA02 [21604447]
—
—
—
—
—
—
2.7e+00
—
—
—
—
—
—
—
—
—
—
—
—
cases:1.45%
controls:0.10%
—
—
—
—
—
—
14
9
949
9453
Schizophrenia, unspecified
F20.9 [45576533]
-1.0e+50
—
—
—
—
—
2.7e+00
cases:0.00%
controls:0.07%
—
—
—
—
—
—
—
—
—
—
cases:1.25%
controls:0.08%
0
7
993
9719
—
—
—
—
—
12
8
951
9454
Developmental disorder of scholastic skills, unspecified
F81.9 [45581474]
—
—
—
—
—
—
2.6e+00
—
—
—
—
—
—
—
—
—
—
—
—
cases:0.73%
controls:0.05%
—
—
—
—
—
—
7
5
956
9457
Cerebral infarction, unspecified
I63.9 [45596216]
1.6e+00
2.6e+00
—
—
—
—
9.8e-01
cases:0.60%
controls:0.12%
cases:0.70%
controls:0.05%
—
—
—
—
—
—
—
—
cases:0.73%
controls:0.27%
6
12
987
9714
7
5
990
9755
—
—
—
—
7
26
956
9436
FEV1 --post bronchodilation
20155-8 [3023550]
1.2e+00
—
—
—
—
1.1e+00
1.3e+00
cases:1.21%
controls:0.35%
—
—
—
—
—
—
—
—
cases:0.50%
controls:0.16%
cases:1.66%
controls:0.44%
12
34
981
9692
—
—
—
—
5
16
987
9721
16
42
947
9420
FEV1 percent change
69983-5 [42868472]
1.2e+00
—
—
—
—
1.1e+00
1.3e+00
cases:1.21%
controls:0.35%
—
—
—
—
—
—
—
—
cases:0.50%
controls:0.16%
cases:1.66%
controls:0.44%
12
34
981
9692
—
—
—
—
5
16
987
9721
16
42
947
9420
FEV1/FVC --post bronchodilation
69970-2 [42868459]
1.2e+00
—
—
—
—
1.1e+00
1.3e+00
cases:1.21%
controls:0.35%
—
—
—
—
—
—
—
—
cases:0.50%
controls:0.16%
cases:1.66%
controls:0.44%
12
34
981
9692
—
—
—
—
5
16
987
9721
16
42
947
9420
Forced vital capacity [Volume] Respiratory system --post bronchodilation
19875-4 [3001668]
1.2e+00
—
—
—
—
1.1e+00
1.3e+00
cases:1.21%
controls:0.35%
—
—
—
—
—
—
—
—
cases:0.50%
controls:0.16%
cases:1.66%
controls:0.44%
12
34
981
9692
—
—
—
—
5
16
987
9721
16
42
947
9420
FVC percent change Respiratory system
69982-7 [42868471]
1.2e+00
—
—
—
—
1.1e+00
1.3e+00
cases:1.21%
controls:0.35%
—
—
—
—
—
—
—
—
cases:0.50%
controls:0.16%
cases:1.66%
controls:0.44%
12
34
981
9692
—
—
—
—
5
16
987
9721
16
42
947
9420
Neutrophils [#/volume] in Blood by Automated count
751-8 [3013650]
-3.7e-02
1.6e-01
—
—
1.1e+00
9.2e-01
5.7e-01
cases:3.22%
controls:3.34%
cases:2.81%
controls:2.41%
—
—
—
—
cases:1.41%
controls:0.48%
cases:4.94%
controls:2.03%
cases:7.79%
controls:4.58%
32
325
961
9401
28
235
969
9525
—
—
14
47
982
9711
49
198
943
9539
75
433
888
9029
venlafaxine; oral
N06AX16 [21604745]
1.4e+00
1.2e+00
—
—
—
6.8e-01
5.9e-01
cases:2.42%
controls:0.62%
cases:1.40%
controls:0.44%
—
—
—
—
—
—
cases:1.01%
controls:0.51%
cases:2.39%
controls:1.34%
24
60
969
9666
14
43
983
9717
—
—
—
10
50
982
9687
23
127
940
9335
Creatinine [Moles/volume] in Serum or Plasma
14682-9 [3020564]
7.9e-02
5.9e-01
9.4e-01
—
1.0e+00
2.9e-01
2.3e-01
cases:6.55%
controls:6.08%
cases:8.32%
controls:4.80%
cases:2.71%
controls:1.08%
—
—
cases:2.41%
controls:0.89%
cases:6.55%
controls:4.98%
cases:14.43%
controls:11.85%
65
591
928
9135
83
468
914
9292
27
105
970
9655
—
24
87
972
9671
65
485
927
9252
139
1121
824
8341
Physiotherapist
Z3226 [2001311560]
4.0e-01
8.1e-01
-1.0e+50
—
—
1.6e+00
8.9e-01
cases:2.22%
controls:1.49%
cases:0.80%
controls:0.36%
cases:0.00%
controls:0.05%
—
—
—
—
cases:1.31%
controls:0.26%
cases:2.39%
controls:0.99%
22
145
971
9581
8
35
989
9725
0
5
997
9755
—
—
13
25
979
9712
23
94
940
9368
nitrazepam; oral
N05CD02 [21604637]
—
—
—
—
—
—
2.5e+00
—
—
—
—
—
—
—
—
—
—
—
—
cases:1.04%
controls:0.08%
—
—
—
—
—
—
10
8
953
9454
Pulmonary Disease
29 [38004472]
3.8e-01
5.5e-01
1.7e+00
—
9.4e-01
8.0e-01
3.2e-01
cases:3.22%
controls:2.22%
cases:1.91%
controls:1.11%
cases:0.90%
controls:0.16%
—
—
cases:0.60%
controls:0.24%
cases:2.62%
controls:1.19%
cases:4.36%
controls:3.21%
32
216
961
9510
19
108
978
9652
9
16
988
9744
—
6
23
990
9735
26
116
966
9621
42
304
921
9158
Eosinophils [#/volume] in Blood
26449-9 [3013115]
-9.4e-02
2.8e-02
—
—
1.1e+00
8.0e-01
5.8e-01
cases:2.92%
controls:3.20%
cases:2.31%
controls:2.24%
—
—
—
—
cases:1.31%
controls:0.43%
cases:4.33%
controls:1.99%
cases:7.48%
controls:4.33%
29
311
964
9415
23
219
974
9541
—
—
13
42
983
9716
43
194
949
9543
72
410
891
9052
Unspecified mood [affective] disorder
F39 [45591137]
1.6e+00
2.5e+00
—
—
—
—
—
cases:0.50%
controls:0.10%
cases:0.60%
controls:0.05%
—
—
—
—
—
—
—
—
—
—
5
10
988
9716
6
5
991
9755
—
—
—
—
—
Neuropsychological investigation
XA800 [2001300412]
9.4e-01
1.5e+00
—
—
—
1.8e+00
2.5e+00
cases:0.70%
controls:0.28%
cases:0.80%
controls:0.17%
—
—
—
—
—
—
cases:0.60%
controls:0.10%
cases:2.28%
controls:0.20%
7
27
986
9699
8
17
989
9743
—
—
—
6
10
986
9727
22
19
941
9443
Outcome of delivery
Z37 [45581024]
-7.8e-02
-1.5e-01
-1.0e+50
—
2.4e+00
-2.9e-01
-2.0e-01
cases:5.34%
controls:5.75%
cases:1.30%
controls:1.52%
cases:0.00%
controls:0.22%
—
—
cases:1.51%
controls:0.13%
cases:1.51%
controls:2.00%
cases:6.02%
controls:7.26%
53
559
940
9167
13
148
984
9612
0
21
997
9739
—
15
13
981
9745
15
195
977
9542
58
687
905
8775
Addiction caused by alcohol UNS
F10.29 [2000501684]
—
—
—
—
—
—
2.4e+00
—
—
—
—
—
—
—
—
—
—
—
—
cases:0.83%
controls:0.07%
—
—
—
—
—
—
8
7
955
9455
zopiclone; oral
N05CF01 [21604654]
9.3e-01
8.0e-01
1.2e+00
—
—
5.1e-01
6.9e-01
cases:3.93%
controls:1.59%
cases:2.51%
controls:1.15%
cases:0.60%
controls:0.17%
—
—
—
—
cases:2.52%
controls:1.53%
cases:6.23%
controls:3.23%
39
155
954
9571
25
112
972
9648
6
17
991
9743
—
—
25
149
967
9588
60
306
903
9156
Troponin T.cardiac [Mass/volume] in Serum or Plasma
6598-7 [3019800]
3.0e-01
1.6e+00
—
—
—
6.0e-01
7.6e-01
cases:1.01%
controls:0.75%
cases:1.81%
controls:0.36%
—
—
—
—
—
—
cases:0.71%
controls:0.39%
cases:2.80%
controls:1.33%
10
73
983
9653
18
35
979
9725
—
—
—
7
38
985
9699
27
126
936
9336
ECG with 12 standard connections
XF400 [2001303368]
5.5e-01
1.3e+00
—
—
—
1.1e+00
1.1e+00
cases:1.81%
controls:1.05%
cases:1.91%
controls:0.51%
—
—
—
—
—
—
cases:0.81%
controls:0.26%
cases:2.70%
controls:0.95%
18
102
975
9624
19
50
978
9710
—
—
—
8
25
984
9712
26
90
937
9372
Hemolysis interference index of Serum or Plasma
46424-8 [3052851]
—
—
—
—
—
—
2.3e+00
—
—
—
—
—
—
—
—
—
—
—
—
cases:0.73%
controls:0.07%
—
—
—
—
—
—
7
7
956
9455
Other specified extrapyramidal and movement disorders
G25.8 [45542878]
—
—
—
—
—
—
2.3e+00
—
—
—
—
—
—
—
—
—
—
—
—
cases:0.62%
controls:0.06%
—
—
—
—
—
—
6
6
957
9456
thioridazine; oral
N05AC02 [21604512]
—
—
—
—
—
—
2.2e+00
—
—
—
—
—
—
—
—
—
—
—
—
cases:0.93%
controls:0.11%
—
—
—
—
—
—
9
10
954
9452
Carbon dioxide [Partial pressure] in Arterial blood
2019-8 [3027946]
—
1.5e+00
—
—
—
2.2e+00
9.4e-01
—
—
cases:0.60%
controls:0.13%
—
—
—
—
—
—
cases:0.81%
controls:0.09%
cases:0.73%
controls:0.29%
—
6
13
991
9747
—
—
—
8
9
984
9728
7
27
956
9435
pH of Arterial blood
2744-1 [3019977]
—
1.6e+00
—
—
—
2.2e+00
7.8e-01
—
—
cases:0.60%
controls:0.12%
—
—
—
—
—
—
cases:0.81%
controls:0.09%
cases:0.62%
controls:0.29%
—
6
12
991
9748
—
—
—
8
9
984
9728
6
27
957
9435
Oxygen [Partial pressure] in Arterial blood
2703-7 [3027801]
—
1.5e+00
—
—
—
2.2e+00
9.4e-01
—
—
cases:0.60%
controls:0.13%
—
—
—
—
—
—
cases:0.81%
controls:0.09%
cases:0.73%
controls:0.29%
—
6
13
991
9747
—
—
—
8
9
984
9728
7
27
956
9435
Fall on same level from slipping, tripping and stumbling
W01 [45756243]
4.3e-01
1.0e+00
—
—
—
1.4e+00
7.3e-01
cases:2.01%
controls:1.32%
cases:1.30%
controls:0.47%
—
—
—
—
—
—
cases:1.61%
controls:0.39%
cases:4.15%
controls:2.04%
20
128
973
9598
13
46
984
9714
—
—
—
16
38
976
9699
40
193
923
9269
Paranoid schizophrenia continuous
F20.00 [2000501920]
—
—
—
—
—
—
2.1e+00
—
—
—
—
—
—
—
—
—
—
—
—
cases:0.62%
controls:0.07%
—
—
—
—
—
—
6
7
957
9455
Hemoglobin [Mass/volume] in Arterial blood
30313-1 [3002173]
—
—
—
—
—
2.1e+00
8.1e-01
—
—
—
—
—
—
—
—
—
—
cases:0.60%
controls:0.07%
cases:0.52%
controls:0.23%
—
—
—
—
—
6
7
986
9730
5
22
958
9440
Depressive episode, unspecified
F32.9 [45571760]
1.1e+00
8.2e-01
—
—
—
3.9e-01
9.6e-01
cases:2.32%
controls:0.75%
cases:0.90%
controls:0.40%
—
—
—
—
—
—
cases:0.60%
controls:0.41%
cases:3.74%
controls:1.46%
23
73
970
9653
9
39
988
9721
—
—
—
6
40
986
9697
36
138
927
9324
Other and unspecified symptoms and signs involving the nervous and musculoskeletal systems
R29.8 [45587505]
1.2e+00
2.1e+00
—
—
—
1.5e+00
8.8e-01
cases:0.91%
controls:0.28%
cases:1.30%
controls:0.16%
—
—
—
—
—
—
cases:0.50%
controls:0.11%
cases:1.14%
controls:0.48%
9
27
984
9699
13
16
984
9744
—
—
—
5
11
987
9726
11
45
952
9417
alprazolam; oral
N05BA12 [21604577]
1.2e+00
1.2e+00
—
—
—
4.9e-01
8.9e-01
cases:1.71%
controls:0.53%
cases:0.90%
controls:0.29%
—
—
—
—
—
—
cases:0.60%
controls:0.37%
cases:2.28%
controls:0.95%
17
52
976
9674
9
28
988
9732
—
—
—
6
36
986
9701
22
90
941
9372
chlorprothixene; oral, parenteral
N05AF03 [21604533]
2.0e+00
1.9e+00
—
—
—
—
1.6e+00
cases:0.70%
controls:0.09%
cases:0.50%
controls:0.07%
—
—
—
—
—
—
—
—
cases:0.62%
controls:0.13%
7
9
986
9717
5
7
992
9753
—
—
—
—
6
12
957
9450
Buprenorphine [Presence] in Urine by Screen method
93494-3 [1001926]
6.0e-01
2.0e+00
—
—
—
—
8.1e-01
cases:0.50%
controls:0.28%
cases:0.70%
controls:0.09%
—
—
—
—
—
—
—
—
cases:1.35%
controls:0.60%
5
27
988
9699
7
9
990
9751
—
—
—
—
13
57
950
9405
Cocaine [Presence] in Urine
3397-7 [3016879]
7.3e-01
2.0e+00
—
—
—
—
6.5e-01
cases:0.70%
controls:0.34%
cases:0.70%
controls:0.09%
—
—
—
—
—
—
—
—
cases:1.35%
controls:0.71%
7
33
986
9693
7
9
990
9751
—
—
—
—
13
67
950
9395
Medical observation and evaluation for suspected diseases and conditions, ruled out
Z03 [45552058]
—
—
—
—
—
—
2.0e+00
—
—
—
—
—
—
—
—
—
—
—
—
cases:1.56%
controls:0.21%
—
—
—
—
—
—
15
20
948
9442
Contusion of elbow
S50.0 [45597855]
-1.0e+50
—
—
—
—
—
2.0e+00
cases:0.00%
controls:0.15%
—
—
—
—
—
—
—
—
—
—
cases:0.62%
controls:0.08%
0
15
993
9711
—
—
—
—
—
6
8
957
9454
pH of Specimen
17433-4 [3019225]
—
2.0e+00
—
—
—
—
1.1e+00
—
—
cases:0.90%
controls:0.12%
—
—
—
—
—
—
—
—
cases:0.93%
controls:0.33%
—
9
12
988
9748
—
—
—
—
9
31
954
9431
Sequelae of cerebral infarction
I69.3 [45533476]
1.9e+00
—
—
—
—
1.9e+00
2.0e+00
cases:0.50%
controls:0.07%
—
—
—
—
—
—
—
—
cases:0.60%
controls:0.09%
cases:1.35%
controls:0.19%
5
7
988
9719
—
—
—
—
6
9
986
9728
13
18
950
9444
pH of Venous blood
2746-6 [3012544]
—
3.5e-01
1.5e+00
—
2.0e+00
4.2e-01
7.5e-01
—
—
cases:1.10%
controls:0.78%
cases:0.80%
controls:0.17%
—
—
cases:0.80%
controls:0.11%
cases:0.91%
controls:0.60%
cases:1.97%
controls:0.94%
—
11
76
986
9684
8
17
989
9743
—
8
11
988
9747
9
58
983
9679
19
89
944
9373
Pain localized to other parts of lower abdomen
R10.3 [45534426]
6.2e-01
3.6e-01
—
—
—
1.2e+00
7.4e-01
cases:2.01%
controls:1.09%
cases:0.60%
controls:0.42%
—
—
—
—
—
—
cases:1.21%
controls:0.36%
cases:4.15%
controls:2.02%
20
106
973
9620
6
41
991
9719
—
—
—
12
35
980
9702
40
191
923
9271
perphenazine; oral, parenteral, rectal
N05AB03 [21604502]
1.0e+00
1.5e+00
—
—
—
1.7e+00
1.9e+00
cases:0.50%
controls:0.19%
cases:0.60%
controls:0.13%
—
—
—
—
—
—
cases:0.71%
controls:0.13%
cases:1.66%
controls:0.24%
5
18
988
9708
6
13
991
9747
—
—
—
7
13
985
9724
16
23
947
9439
Bronchopneumonia, organism unspecified[PNEUMONIA NUD]
4859X [2000403973]
1.9e+00
—
—
—
—
—
—
cases:0.70%
controls:0.10%
—
—
—
—
—
—
—
—
—
—
—
—
7
10
986
9716
—
—
—
—
—
—
Migraine, unspecified
G43.9 [45595943]
8.2e-01
1.9e+00
—
—
—
—
7.9e-01
cases:0.91%
controls:0.40%
cases:0.70%
controls:0.10%
—
—
—
—
—
—
—
—
cases:1.25%
controls:0.57%
9
39
984
9687
7
10
990
9750
—
—
—
—
12
54
951
9408
General symptom/complaint other
A29 [2002000163]
5.3e-01
1.9e+00
—
—
—
—
7.6e-01
cases:0.50%
controls:0.30%
cases:0.70%
controls:0.10%
—
—
—
—
—
—
—
—
cases:0.83%
controls:0.39%
5
29
988
9697
7
10
990
9750
—
—
—
—
8
37
955
9425
pH of Serum or Plasma
2753-2 [3018418]
2.3e-01
1.1e+00
1.8e+00
—
—
1.0e+00
7.9e-01
cases:1.11%
controls:0.88%
cases:1.81%
controls:0.59%
cases:0.50%
controls:0.08%
—
—
—
—
cases:1.31%
controls:0.48%
cases:3.12%
controls:1.44%
11
86
982
9640
18
58
979
9702
5
8
992
9752
—
—
13
47
979
9690
30
136
933
9326
Carbon dioxide [Partial pressure] in Venous blood
2021-4 [3021447]
—
3.4e-01
1.6e+00
—
1.9e+00
4.2e-01
7.8e-01
—
—
cases:1.10%
controls:0.79%
cases:0.80%
controls:0.16%
—
—
cases:0.80%
controls:0.12%
cases:0.91%
controls:0.60%
cases:2.08%
controls:0.96%
—
11
77
986
9683
8
16
989
9744
—
8
12
988
9746
9
58
983
9679
20
91
943
9371
Clinic/Center
261Q00000X [38004207]
1.9e+00
—
—
—
—
—
—
cases:0.81%
controls:0.12%
—
—
—
—
—
—
—
—
—
—
—
—
8
12
985
9714
—
—
—
—
—
—
Prothrombin time (PT) actual/Normal
5894-1 [3033658]
-7.8e-02
1.6e-01
—
—
—
1.1e+00
7.7e-01
cases:1.21%
controls:1.31%
cases:1.10%
controls:0.94%
—
—
—
—
—
—
cases:1.71%
controls:0.58%
cases:3.12%
controls:1.47%
12
127
981
9599
11
92
986
9668
—
—
—
17
56
975
9681
30
139
933
9323
Mental and behavioural disorders due to use of alcohol, Harmful use
F10.1 [45595844]
8.6e-01
1.6e+00
—
—
—
1.9e+00
1.9e+00
cases:0.70%
controls:0.30%
cases:0.50%
controls:0.10%
—
—
—
—
—
—
cases:0.60%
controls:0.09%
cases:2.28%
controls:0.36%
7
29
986
9697
5
10
992
9750
—
—
—
6
9
986
9728
22
34
941
9428
Thorax X-ray examination
GD1AA [2001303617]
3.1e-01
9.2e-01
—
—
—
9.8e-01
9.3e-01
cases:2.11%
controls:1.55%
cases:1.71%
controls:0.69%
—
—
—
—
—
—
cases:1.41%
controls:0.53%
cases:4.57%
controls:1.86%
21
151
972
9575
17
67
980
9693
—
—
—
14
52
978
9685
44
176
919
9286
Social phobias
F40.1 [45595907]
1.8e+00
—
—
—
—
—
1.3e+00
cases:0.70%
controls:0.11%
—
—
—
—
—
—
—
—
—
—
cases:0.62%
controls:0.17%
7
11
986
9715
—
—
—
—
—
6
16
957
9446
disulfiram; oral
N07BB01 [21604821]
8.5e-01
—
—
—
—
—
1.8e+00
cases:0.50%
controls:0.22%
—
—
—
—
—
—
—
—
—
—
cases:1.04%
controls:0.17%
5
21
988
9705
—
—
—
—
—
10
16
953
9446
Dislocation of shoulder joint
S43.0 [45573622]
—
1.6e+00
—
—
—
—
1.8e+00
—
—
cases:0.50%
controls:0.10%
—
—
—
—
—
—
—
—
cases:0.83%
controls:0.14%
—
5
10
992
9750
—
—
—
—
8
13
955
9449
Person consulting for explanation of investigation findings
Z71.2 [45552100]
2.2e-01
—
—
—
—
1.1e+00
6.8e-01
cases:1.51%
controls:1.21%
—
—
—
—
—
—
—
—
cases:1.41%
controls:0.46%
cases:3.74%
controls:1.93%
15
118
978
9608
—
—
—
—
14
45
978
9692
36
183
927
9279
Panic disorder [episodic paroxysmal anxiety]
F41.0 [45562047]
—
—
—
—
—
—
1.8e+00
—
—
—
—
—
—
—
—
—
—
—
—
cases:0.93%
controls:0.16%
—
—
—
—
—
—
9
15
954
9447
citalopram; oral, parenteral
N06AB04 [21604712]
6.7e-01
1.1e+00
—
—
—
8.2e-01
6.9e-01
cases:3.02%
controls:1.56%
cases:2.11%
controls:0.73%
—
—
—
—
—
—
cases:2.12%
controls:0.94%
cases:4.98%
controls:2.57%
30
152
963
9574
21
71
976
9689
—
—
—
21
92
971
9645
48
243
915
9219
Fall into hole or other opening in surface
E883A [2000408881]
7.1e-01
—
—
—
—
—
1.8e+00
cases:0.60%
controls:0.30%
—
—
—
—
—
—
—
—
—
—
cases:1.04%
controls:0.18%
6
29
987
9697
—
—
—
—
—
10
17
953
9445
Short blood count panel - Blood
55429-5 [40758558]
-1.9e-01
9.4e-02
—
—
9.7e-01
1.1e+00
6.9e-01
cases:1.81%
controls:2.18%
cases:1.30%
controls:1.19%
—
—
—
—
cases:0.70%
controls:0.27%
cases:2.02%
controls:0.71%
cases:3.43%
controls:1.74%
18
212
975
9514
13
116
984
9644
—
—
7
26
989
9732
20
69
972
9668
33
165
930
9297
Unspecified fall
W19 [45756257]
—
1.3e+00
—
—
—
1.7e+00
8.1e-01
—
—
cases:0.70%
controls:0.18%
—
—
—
—
—
—
cases:0.81%
controls:0.14%
cases:1.35%
controls:0.60%
—
7
18
990
9742
—
—
—
8
14
984
9723
13
57
950
9405
Emotionally unstable personality disorder, impulsive
F60.30 [2000502022]
1.3e+00
—
—
—
—
—
1.7e+00
cases:0.50%
controls:0.13%
—
—
—
—
—
—
—
—
—
—
cases:0.83%
controls:0.16%
5
13
988
9713
—
—
—
—
—
8
15
955
9447
Knee and lower leg MRI examination with high intensity magnet
NG1BG [2001308056]
-1.0e+50
—
—
—
—
—
1.6e+00
cases:0.00%
controls:0.05%
—
—
—
—
—
—
—
—
—
—
cases:1.25%
controls:0.24%
0
5
993
9721
—
—
—
—
—
12
23
951
9439
Differential panel, method unspecified - Blood
69738-3 [42870588]
4.4e-02
2.7e-01
—
—
9.0e-01
9.6e-01
6.7e-01
cases:2.11%
controls:2.03%
cases:2.01%
controls:1.54%
—
—
—
—
cases:0.80%
controls:0.33%
cases:3.53%
controls:1.39%
cases:5.50%
controls:2.91%
21
197
972
9529
20
150
977
9610
—
—
8
32
988
9726
35
135
957
9602
53
275
910
9187
Counselling and guidance which enhance independent living
R2130 [2001310196]
-3.5e-01
6.4e-01
—
—
—
1.6e+00
7.1e-01
cases:0.60%
controls:0.85%
cases:0.60%
controls:0.32%
—
—
—
—
—
—
cases:1.31%
controls:0.27%
cases:1.35%
controls:0.67%
6
83
987
9643
6
31
991
9729
—
—
—
13
26
979
9711
13
63
950
9399
Problems related to unwanted pregnancy
Z64.0 [45581053]
-1.0e+50
—
—
—
—
—
1.6e+00
cases:0.00%
controls:0.13%
—
—
—
—
—
—
—
—
—
—
cases:0.93%
controls:0.19%
0
13
993
9713
—
—
—
—
—
9
18
954
9444
Malaise and fatigue
R53 [45553741]
4.1e-02
1.1e+00
—
—
—
1.6e+00
5.6e-01
cases:0.50%
controls:0.48%
cases:0.70%
controls:0.24%
—
—
—
—
—
—
cases:1.21%
controls:0.26%
cases:2.08%
controls:1.19%
5
47
988
9679
7
23
990
9737
—
—
—
12
25
980
9712
20
113
943
9349
Observation for suspected disease or condition, unspecified
Z03.9 [45552062]
6.0e-01
1.6e+00
—
—
—
1.2e+00
5.3e-01
cases:1.61%
controls:0.89%
cases:1.20%
controls:0.26%
—
—
—
—
—
—
cases:1.01%
controls:0.30%
cases:1.87%
controls:1.11%
16
87
977
9639
12
25
985
9735
—
—
—
10
29
982
9708
18
105
945
9357
Monocytes/Leukocytes in Blood
26485-3 [3019069]
-1.1e-01
5.0e-02
—
—
1.1e+00
9.2e-01
6.3e-01
cases:2.72%
controls:3.02%
cases:2.21%
controls:2.10%
—
—
—
—
cases:1.20%
controls:0.42%
cases:4.23%
controls:1.73%
cases:7.06%
controls:3.90%
27
294
966
9432
22
205
975
9555
—
—
12
41
984
9717
42
168
950
9569
68
369
895
9093
Eosinophils/Leukocytes in Blood
26450-7 [3006504]
-9.8e-02
4.5e-02
—
—
1.1e+00
9.0e-01
6.4e-01
cases:2.72%
controls:2.99%
cases:2.21%
controls:2.11%
—
—
—
—
cases:1.20%
controls:0.42%
cases:4.13%
controls:1.73%
cases:7.06%
controls:3.85%
27
291
966
9435
22
206
975
9554
—
—
12
41
984
9717
41
168
951
9569
68
364
895
9098
buprenorphine; parenteral, sublingual, transdermal
N02AE01 [21604287]
—
—
—
—
—
1.2e+00
1.5e+00
—
—
—
—
—
—
—
—
—
—
cases:0.50%
controls:0.15%
cases:1.45%
controls:0.32%
—
—
—
—
—
5
15
987
9722
14
30
949
9432
Basophils/Leukocytes in Blood
30180-4 [3022096]
-9.5e-02
4.5e-02
—
—
1.1e+00
8.9e-01
6.4e-01
cases:2.72%
controls:2.98%
cases:2.21%
controls:2.11%
—
—
—
—
cases:1.20%
controls:0.42%
cases:4.13%
controls:1.74%
cases:7.06%
controls:3.87%
27
290
966
9436
22
206
975
9554
—
—
12
41
984
9717
41
169
951
9568
68
366
895
9096
Hearing complaint
H02 [2002000476]
-1.0e+50
—
—
—
—
—
1.5e+00
cases:0.00%
controls:0.16%
—
—
—
—
—
—
—
—
—
—
cases:1.04%
controls:0.23%
0
16
993
9710
—
—
—
—
—
10
22
953
9440
Assessment of need for psychiatric treatment
IAA01 [2001304011]
—
—
—
—
—
—
1.5e+00
—
—
—
—
—
—
—
—
—
—
—
—
cases:1.04%
controls:0.23%
—
—
—
—
—
—
10
22
953
9440
Lymphocytes/Leukocytes in Blood
26478-8 [3002030]
-1.7e-01
5.2e-02
—
—
1.1e+00
9.0e-01
5.9e-01
cases:2.72%
controls:3.20%
cases:2.31%
controls:2.19%
—
—
—
—
cases:1.20%
controls:0.42%
cases:4.33%
controls:1.81%
cases:7.17%
controls:4.09%
27
311
966
9415
23
214
974
9546
—
—
12
41
984
9717
43
176
949
9561
69
387
894
9075
Ultrasound examination of upper part of abdomen
JN1AE [2001305517]
—
-1.0e+50
—
—
—
-1.0e+50
1.5e+00
—
—
cases:0.00%
controls:0.07%
—
—
—
—
—
—
cases:0.00%
controls:0.09%
cases:0.93%
controls:0.21%
—
0
7
997
9753
—
—
—
0
9
992
9728
9
20
954
9442
Skin texture symptom/complaint
S21 [2002000986]
1.5e+00
—
—
—
—
—
5.1e-01
cases:0.91%
controls:0.21%
—
—
—
—
—
—
—
—
—
—
cases:1.14%
controls:0.69%
9
20
984
9706
—
—
—
—
—
11
65
952
9397
Neutrophils/Leukocytes in Blood
26511-6 [3018010]
-1.1e-01
6.2e-02
—
—
1.0e+00
8.9e-01
6.0e-01
cases:2.82%
controls:3.13%
cases:2.31%
controls:2.17%
—
—
—
—
cases:1.20%
controls:0.43%
cases:4.13%
controls:1.75%
cases:7.06%
controls:3.99%
28
304
965
9422
23
212
974
9548
—
—
12
42
984
9716
41
170
951
9567
68
378
895
9084
Asthma
J45 [45596282]
1.7e-01
1.5e+00
—
—
—
—
4.3e-01
cases:1.21%
controls:1.02%
cases:1.00%
controls:0.24%
—
—
—
—
—
—
—
—
cases:1.87%
controls:1.23%
12
99
981
9627
10
23
987
9737
—
—
—
—
18
116
945
9346
General Surgery
2 [38004447]
3.6e-01
4.8e-01
5.9e-01
—
8.0e-01
4.3e-01
6.0e-01
cases:17.72%
controls:13.08%
cases:6.72%
controls:4.26%
cases:1.30%
controls:0.73%
—
—
cases:1.20%
controls:0.54%
cases:6.75%
controls:4.51%
cases:23.88%
controls:14.71%
176
1272
817
8454
67
416
930
9344
13
71
984
9689
—
12
53
984
9705
67
439
925
9298
230
1392
733
8070
Procedure duration 60 to 89 minutes
ZXE11 [2001311402]
-2.1e-02
1.2e+00
—
—
—
1.3e+00
1.4e+00
cases:0.60%
controls:0.62%
cases:0.60%
controls:0.18%
—
—
—
—
—
—
cases:0.71%
controls:0.20%
cases:1.14%
controls:0.27%
6
60
987
9666
6
18
991
9742
—
—
—
7
19
985
9718
11
26
952
9436
UNS Panic Syndrome
F41.09 [2000501997]
1.7e+00
—
—
—
—
—
1.4e+00
cases:0.70%
controls:0.12%
—
—
—
—
—
—
—
—
—
—
cases:1.14%
controls:0.29%
7
12
986
9714
—
—
—
—
—
11
27
952
9435
doxepin; oral, parenteral
N06AA12 [21604699]
1.0e+00
1.5e+00
—
—
—
1.5e+00
1.4e+00
cases:0.70%
controls:0.26%
cases:0.50%
controls:0.11%
—
—
—
—
—
—
cases:0.50%
controls:0.11%
cases:1.35%
controls:0.34%
7
25
986
9701
5
11
992
9749
—
—
—
5
11
987
9726
13
32
950
9430
Basophils [#/volume] in Blood
26444-0 [3006315]
-2.1e-01
5.2e-02
—
—
1.1e+00
8.1e-01
5.6e-01
cases:2.52%
controls:3.08%
cases:2.31%
controls:2.19%
—
—
—
—
cases:1.20%
controls:0.42%
cases:4.13%
controls:1.89%
cases:6.96%
controls:4.10%
25
300
968
9426
23
214
974
9546
—
—
12
41
984
9717
41
184
951
9553
67
388
896
9074
Monocytes [#/volume] in Blood
26484-6 [3001604]
-2.1e-01
5.2e-02
—
—
1.1e+00
8.1e-01
5.6e-01
cases:2.52%
controls:3.09%
cases:2.31%
controls:2.19%
—
—
—
—
cases:1.20%
controls:0.42%
cases:4.13%
controls:1.89%
cases:6.96%
controls:4.10%
25
301
968
9425
23
214
974
9546
—
—
12
41
984
9717
41
184
951
9553
67
388
896
9074
Medical examin/health eval partial
-31 [2002000102]
—
-1.0e+50
—
—
—
—
1.4e+00
—
—
cases:0.00%
controls:0.08%
—
—
—
—
—
—
—
—
cases:1.14%
controls:0.30%
—
0
8
997
9752
—
—
—
—
11
28
952
9434
Lymphocytes [#/volume] in Blood
26474-7 [3019198]
-2.3e-01
1.9e-02
—
—
1.1e+00
7.9e-01
5.6e-01
cases:2.62%
controls:3.26%
cases:2.31%
controls:2.26%
—
—
—
—
cases:1.20%
controls:0.42%
cases:4.13%
controls:1.92%
cases:7.27%
controls:4.27%
26
317
967
9409
23
221
974
9539
—
—
12
41
984
9717
41
187
951
9550
70
404
893
9058
Folate [Moles/volume] in Red Blood Cells
14731-4 [3019309]
—
—
—
—
—
—
1.3e+00
—
—
—
—
—
—
—
—
—
—
—
—
cases:1.66%
controls:0.44%
—
—
—
—
—
—
16
42
947
9420
Sytologyspecimen from mouth of uterus
XLD00 [2001306651]
1.3e+00
—
—
—
—
1.3e+00
1.3e+00
cases:1.01%
controls:0.29%
—
—
—
—
—
—
—
—
cases:0.60%
controls:0.16%
cases:2.18%
controls:0.59%
10
28
983
9698
—
—
—
—
6
16
986
9721
21
56
942
9406
EKG study
11524-6 [3013512]
3.2e-01
1.3e+00
—
—
—
9.0e-01
5.9e-01
cases:0.91%
controls:0.66%
cases:1.40%
controls:0.38%
—
—
—
—
—
—
cases:1.01%
controls:0.41%
cases:2.28%
controls:1.28%
9
64
984
9662
14
37
983
9723
—
—
—
10
40
982
9697
22
121
941
9341
General psychiatric examination, not elsewhere classified
Z00.4 [45605094]
3.2e-01
8.7e-01
—
—
—
7.6e-01
1.3e+00
cases:1.41%
controls:1.03%
cases:0.90%
controls:0.38%
—
—
—
—
—
—
cases:0.81%
controls:0.38%
cases:4.36%
controls:1.26%
14
100
979
9626
9
37
988
9723
—
—
—
8
37
984
9700
42
119
921
9343
tramadol; oral, parenteral, rectal
N02AX02 [21604298]
7.1e-01
5.6e-01
—
—
—
6.7e-01
5.1e-01
cases:3.63%
controls:1.82%
cases:1.60%
controls:0.92%
—
—
—
—
—
—
cases:1.81%
controls:0.93%
cases:5.82%
controls:3.56%
36
177
957
9549
16
90
981
9670
—
—
—
18
91
974
9646
56
337
907
9125
Dedicated profession-specific psychiatric intervention, individual
IEY05 [2001304224]
—
-1.0e+50
-1.0e+50
—
—
1.5e+00
1.2e+00
—
—
cases:0.00%
controls:0.14%
cases:0.00%
controls:0.09%
—
—
—
—
cases:0.60%
controls:0.13%
cases:1.45%
controls:0.44%
—
0
14
997
9746
0
9
997
9751
—
—
6
13
986
9724
14
42
949
9420
General counselling and advice on contraception
Z30.0 [45537624]
—
—
—
—
—
—
1.2e+00
—
—
—
—
—
—
—
—
—
—
—
—
cases:1.87%
controls:0.58%
—
—
—
—
—
—
18
55
945
9407
Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma
21573-1 [3003031]
7.5e-01
1.2e+00
—
—
—
1.1e+00
1.2e+00
cases:0.91%
controls:0.43%
cases:0.60%
controls:0.17%
—
—
—
—
—
—
cases:0.71%
controls:0.25%
cases:3.01%
controls:0.97%
9
42
984
9684
6
17
991
9743
—
—
—
7
24
985
9713
29
92
934
9370
lactulose; oral
A06AD11 [21600571]
3.1e-01
—
—
—
—
1.5e+00
1.1e+00
cases:0.60%
controls:0.44%
—
—
—
—
—
—
—
—
cases:0.50%
controls:0.11%
cases:1.87%
controls:0.61%
6
43
987
9683
—
—
—
—
5
11
987
9726
18
58
945
9404
Examination and observation for other specified reasons
Z04.8 [45552063]
2.0e-02
1.3e+00
—
—
—
9.5e-01
1.1e+00
cases:0.50%
controls:0.49%
cases:0.50%
controls:0.14%
—
—
—
—
—
—
cases:0.50%
controls:0.20%
cases:1.87%
controls:0.63%
5
48
988
9678
5
14
992
9746
—
—
—
5
19
987
9718
18
60
945
9402
Cathetrisation of vein
TPH04 [2001309597]
7.2e-01
1.4e+00
—
—
—
1.6e+00
1.1e+00
cases:1.41%
controls:0.69%
cases:0.70%
controls:0.17%
—
—
—
—
—
—
cases:0.60%
controls:0.12%
cases:2.49%
controls:0.86%
14
67
979
9659
7
17
990
9743
—
—
—
6
12
986
9725
24
81
939
9381
Urinary frequency/urgency
U02 [2002001138]
8.4e-01
—
—
—
—
—
1.1e+00
cases:0.81%
controls:0.35%
—
—
—
—
—
—
—
—
—
—
cases:1.87%
controls:0.64%
8
34
985
9692
—
—
—
—
—
18
61
945
9401
Otolaryngology
4 [38004449]
2.1e-01
4.5e-01
—
—
6.8e-01
6.8e-01
3.9e-01
cases:8.06%
controls:6.63%
cases:3.61%
controls:2.33%
—
—
—
—
cases:0.60%
controls:0.31%
cases:4.13%
controls:2.14%
cases:10.59%
controls:7.41%
80
645
913
9081
36
227
961
9533
—
—
6
30
990
9728
41
208
951
9529
102
701
861
8761
Emergency Room and Inpatient Visit
ERIP [262]
2.3e-02
1.1e+00
—
1.0e+50
—
8.5e-01
2.5e-01
cases:0.70%
controls:0.69%
cases:1.50%
controls:0.52%
—
—
cases:0.50%
controls:0.00%
—
—
cases:1.01%
controls:0.43%
cases:2.28%
controls:1.80%
7
67
986
9659
15
51
982
9709
—
5
0
992
9760
—
10
42
982
9695
22
170
941
9292
Drugs identified in Urine by Screen method Nominal
12286-1 [3011288]
8.0e-01
—
—
—
—
—
1.1e+00
cases:0.50%
controls:0.23%
—
—
—
—
—
—
—
—
—
—
cases:1.66%
controls:0.58%
5
22
988
9704
—
—
—
—
—
16
55
947
9407
Laceration/cut
S18 [2002000983]
3.1e-01
1.1e+00
—
—
-1.0e+50
5.5e-01
9.9e-02
cases:2.01%
controls:1.48%
cases:1.40%
controls:0.49%
—
—
—
—
cases:0.00%
controls:0.09%
cases:1.01%
controls:0.59%
cases:2.70%
controls:2.45%
20
144
973
9582
14
48
983
9712
—
—
0
9
996
9749
10
57
982
9680
26
232
937
9230
Glomerular filtration rate [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)/1.73 sq M
62238-1 [40764999]
3.6e-01
6.4e-01
1.0e+00
—
1.2e+00
4.8e-01
3.9e-01
cases:4.13%
controls:2.92%
cases:4.31%
controls:2.33%
cases:1.20%
controls:0.44%
—
—
cases:1.20%
controls:0.37%
cases:3.93%
controls:2.48%
cases:9.87%
controls:6.89%
41
284
952
9442
43
227
954
9533
12
43
985
9717
—
12
36
984
9722
39
241
953
9496
95
652
868
8810
Infectious Disease
44 [38004484]
4.9e-01
—
—
—
—
-1.0e+50
1.0e+00
cases:0.50%
controls:0.31%
—
—
—
—
—
—
—
—
cases:0.00%
controls:0.14%
cases:1.87%
controls:0.68%
5
30
988
9696
—
—
—
—
0
14
992
9723
18
64
945
9398
Osmolality of Urine
2695-5 [3026782]
-4.4e-01
2.9e-01
—
—
—
—
1.0e+00
cases:0.81%
controls:1.24%
cases:0.80%
controls:0.60%
—
—
—
—
—
—
—
—
cases:2.28%
controls:0.83%
8
121
985
9605
8
59
989
9701
—
—
—
—
22
79
941
9383
piroxicam; oral, parenteral, rectal
M01AC01 [21603961]
5.4e-01
4.6e-01
—
—
-1.0e+50
3.2e-01
4.5e-01
cases:4.93%
controls:2.93%
cases:1.40%
controls:0.89%
—
—
—
—
cases:0.00%
controls:0.10%
cases:1.41%
controls:1.03%
cases:7.17%
controls:4.68%
49
285
944
9441
14
87
983
9673
—
—
0
10
996
9748
14
100
978
9637
69
443
894
9019
Intravenous general anesthesia
WX404 [2001310807]
-2.7e-01
—
-1.0e+50
—
—
6.8e-01
9.9e-01
cases:1.21%
controls:1.57%
—
—
cases:0.00%
controls:0.05%
—
—
—
—
cases:0.50%
controls:0.26%
cases:1.77%
controls:0.67%
12
153
981
9573
—
0
5
997
9755
—
—
5
25
987
9712
17
63
946
9399
Mixed anxiety and depressive disorder
F41.2 [45566845]
9.6e-01
1.3e+00
—
—
—
1.2e+00
9.8e-01
cases:0.91%
controls:0.35%
cases:0.70%
controls:0.19%
—
—
—
—
—
—
cases:0.81%
controls:0.25%
cases:2.49%
controls:0.95%
9
34
984
9692
7
19
990
9741
—
—
—
8
24
984
9713
24
90
939
9372
Medical abortion, complete or unspecified, without complication
O04.9 [45543909]
-1.2e-01
8.5e-01
—
—
—
—
9.7e-01
cases:0.60%
controls:0.68%
cases:0.50%
controls:0.22%
—
—
—
—
—
—
—
—
cases:2.60%
controls:1.00%
6
66
987
9660
5
21
992
9739
—
—
—
—
25
95
938
9367
Concussion
S06.0 [45582805]
3.2e-01
1.6e+00
—
—
—
1.3e+00
9.7e-01
cases:0.91%
controls:0.66%
cases:0.50%
controls:0.10%
—
—
—
—
—
—
cases:0.81%
controls:0.22%
cases:1.97%
controls:0.76%
9
64
984
9662
5
10
992
9750
—
—
—
8
21
984
9716
19
72
944
9390
metronidazole
D06BX01 [21602096]
7.3e-01
-1.0e+50
—
—
—
-1.0e+50
9.5e-01
cases:0.81%
controls:0.39%
cases:0.00%
controls:0.16%
—
—
—
—
—
—
cases:0.00%
controls:0.26%
cases:1.97%
controls:0.77%
8
38
985
9688
0
16
997
9744
—
—
—
0
25
992
9712
19
73
944
9389
fluoxetine; oral
N06AB03 [21604711]
8.9e-01
7.6e-01
-1.0e+50
—
1.1e+00
5.9e-01
5.5e-01
cases:2.52%
controls:1.05%
cases:1.30%
controls:0.61%
cases:0.00%
controls:0.19%
—
—
cases:0.50%
controls:0.16%
cases:1.31%
controls:0.73%
cases:3.32%
controls:1.94%
25
102
968
9624
13
60
984
9700
0
19
997
9741
—
5
16
991
9742
13
71
979
9666
32
184
931
9278
Physiotherapy
R4110 [2001310233]
2.8e-01
5.5e-01
—
—
—
9.7e-01
8.7e-01
cases:1.91%
controls:1.46%
cases:1.20%
controls:0.70%
—
—
—
—
—
—
cases:1.21%
controls:0.46%
cases:3.95%
controls:1.69%
19
142
974
9584
12
68
985
9692
—
—
—
12
45
980
9692
38
160
925
9302
Ultrasound examination of uterus and parametria
LC2AE [2001306543]
4.9e-01
—
—
—
—
9.5e-01
8.6e-01
cases:0.81%
controls:0.49%
—
—
—
—
—
—
—
—
cases:0.50%
controls:0.20%
cases:2.39%
controls:1.03%
8
48
985
9678
—
—
—
—
5
19
987
9718
23
97
940
9365
Holo-transcobalamin II [Moles/volume] in Serum
72160-5 [43054903]
8.6e-01
1.1e+00
—
—
—
2.1e-01
8.6e-01
cases:1.51%
controls:0.65%
cases:1.20%
controls:0.39%
—
—
—
—
—
—
cases:0.60%
controls:0.49%
cases:4.26%
controls:1.85%
15
63
978
9663
12
38
985
9722
—
—
—
6
48
986
9689
41
175
922
9287
Folate [Moles/volume] in Serum or Plasma
14732-2 [3021960]
—
1.3e+00
—
—
—
—
8.5e-01
—
—
cases:0.70%
controls:0.18%
—
—
—
—
—
—
—
—
cases:2.49%
controls:1.08%
—
7
18
990
9742
—
—
—
—
24
102
939
9360
Observation for other suspected diseases and conditions
Z03.89 [2000503757]
4.1e-01
1.1e+00
—
—
—
—
8.4e-01
cases:1.01%
controls:0.67%
cases:0.80%
controls:0.27%
—
—
—
—
—
—
—
—
cases:2.18%
controls:0.95%
10
65
983
9661
8
26
989
9734
—
—
—
—
21
90
942
9372
More than one and less than three hours
ZXE10 [2001311401]
4.5e-01
7.1e-01
—
—
-1.0e+50
6.4e-01
8.3e-01
cases:3.22%
controls:2.08%
cases:1.40%
controls:0.70%
—
—
—
—
cases:0.00%
controls:0.05%
cases:1.11%
controls:0.59%
cases:4.57%
controls:2.04%
32
202
961
9524
14
68
983
9692
—
—
0
5
996
9753
11
57
981
9680
44
193
919
9269
escitalopram; oral
N06AB10 [21604718]
8.2e-01
9.2e-01
—
—
—
5.5e-01
5.0e-01
cases:2.42%
controls:1.08%
cases:1.60%
controls:0.65%
—
—
—
—
—
—
cases:1.41%
controls:0.82%
cases:3.74%
controls:2.30%
24
105
969
9621
16
63
981
9697
—
—
—
14
80
978
9657
36
218
927
9244
Chest pain, unspecified
R07.4 [45558450]
3.2e-01
—
-1.0e+50
—
—
4.0e-01
8.2e-01
cases:0.91%
controls:0.66%
—
—
cases:0.00%
controls:0.05%
—
—
—
—
cases:0.50%
controls:0.34%
cases:2.39%
controls:1.07%
9
64
984
9662
—
0
5
997
9755
—
—
5
33
987
9704
23
101
940
9361
Exposure to unspecified factor
X59 [45756412]
8.3e-01
1.0e+00
—
—
-1.0e+50
8.3e-01
8.2e-01
cases:1.81%
controls:0.80%
cases:0.80%
controls:0.30%
—
—
—
—
cases:0.00%
controls:0.05%
cases:0.71%
controls:0.31%
cases:3.01%
controls:1.35%
18
78
975
9648
8
29
989
9731
—
—
0
5
996
9753
7
30
985
9707
29
128
934
9334
furosemide; oral, parenteral
C03CA01 [21601518]
2.3e-01
1.3e-01
—
—
—
2.2e-01
8.1e-01
cases:1.21%
controls:0.97%
cases:0.80%
controls:0.71%
—
—
—
—
—
—
cases:1.01%
controls:0.81%
cases:3.32%
controls:1.50%
12
94
981
9632
8
69
989
9691
—
—
—
10
79
982
9658
32
142
931
9320
Restricted health certificate
SPAT1283 [2001700384]
-2.6e-01
3.0e-01
—
—
—
-1.7e-01
7.8e-01
cases:1.31%
controls:1.70%
cases:0.80%
controls:0.59%
—
—
—
—
—
—
cases:0.60%
controls:0.72%
cases:4.36%
controls:2.05%
13
165
980
9561
8
58
989
9702
—
—
—
6
70
986
9667
42
194
921
9268
Headache
R51.80 [2000503603]
3.4e-01
1.0e+00
—
—
—
3.4e-01
7.7e-01
cases:1.31%
controls:0.94%
cases:1.10%
controls:0.39%
—
—
—
—
—
—
cases:0.60%
controls:0.43%
cases:2.70%
controls:1.27%
13
91
980
9635
11
38
986
9722
—
—
—
6
42
986
9695
26
120
937
9342
Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma
1920-8 [3013721]
1.0e-01
5.1e-01
—
—
—
5.2e-01
7.5e-01
cases:1.61%
controls:1.46%
cases:1.30%
controls:0.79%
—
—
—
—
—
—
cases:1.31%
controls:0.78%
cases:4.36%
controls:2.10%
16
142
977
9584
13
77
984
9683
—
—
—
13
76
979
9661
42
199
921
9263
budesonide; inhalant
R03BA02 [21603285]
1.5e-01
7.4e-01
—
—
—
2.5e-01
2.9e-01
cases:2.82%
controls:2.45%
cases:2.71%
controls:1.31%
—
—
—
—
—
—
cases:2.12%
controls:1.66%
cases:4.57%
controls:3.47%
28
238
965
9488
27
128
970
9632
—
—
—
21
162
971
9575
44
328
919
9134
betamethasone
S03BA03 [21605203]
3.4e-01
2.3e-01
—
—
-1.0e+50
6.8e-01
7.4e-01
cases:1.11%
controls:0.79%
cases:0.50%
controls:0.40%
—
—
—
—
cases:0.00%
controls:0.07%
cases:0.91%
controls:0.46%
cases:2.80%
controls:1.36%
11
77
982
9649
5
39
992
9721
—
—
0
7
996
9751
9
45
983
9692
27
129
936
9333
One hour or less
ZXE00 [2001311394]
2.8e-01
4.6e-01
—
—
—
7.1e-01
7.0e-01
cases:4.13%
controls:3.17%
cases:1.40%
controls:0.89%
—
—
—
—
—
—
cases:1.31%
controls:0.65%
cases:5.71%
controls:2.93%
41
308
952
9418
14
87
983
9673
—
—
—
13
63
979
9674
55
277
908
9185
calcium (different salts in combination); oral
A12AA20 [21600872]
7.1e-01
8.5e-01
—
—
—
6.0e-01
6.9e-01
cases:2.42%
controls:1.20%
cases:1.91%
controls:0.82%
—
—
—
—
—
—
cases:1.41%
controls:0.78%
cases:3.74%
controls:1.90%
24
117
969
9609
19
80
978
9680
—
—
—
14
76
978
9661
36
180
927
9282
Transvaginal ultrasound examination of uterus, parametria and lower abdomen
LC2BE [2001306544]
5.1e-01
-1.4e-01
-1.0e+50
—
-1.0e+50
8.1e-01
6.6e-01
cases:2.62%
controls:1.58%
cases:0.50%
controls:0.57%
cases:0.00%
controls:0.07%
—
—
cases:0.00%
controls:0.09%
cases:1.31%
controls:0.59%
cases:5.30%
controls:2.80%
26
154
967
9572
5
56
992
9704
0
7
997
9753
—
0
9
996
9749
13
57
979
9680
51
265
912
9197
Scheduled procedure
ZXD10 [2001311387]
2.9e-01
3.2e-01
—
—
—
5.1e-01
6.6e-01
cases:3.93%
controls:2.96%
cases:1.20%
controls:0.88%
—
—
—
—
—
—
cases:1.11%
controls:0.67%
cases:4.78%
controls:2.54%
39
288
954
9438
12
86
985
9674
—
—
—
11
65
981
9672
46
240
917
9222
amoxicillin and beta-lactamase inhibitor; oral, parenteral
J01CR02 [21602863]
4.9e-02
4.7e-01
—
—
—
1.9e-01
6.4e-01
cases:3.22%
controls:3.07%
cases:1.81%
controls:1.14%
—
—
—
—
—
—
cases:1.31%
controls:1.09%
cases:8.83%
controls:4.87%
32
299
961
9427
18
111
979
9649
—
—
—
13
106
979
9631
85
461
878
9001
orphenadrine, combinations
M03BC51 [21604113]
-3.2e-01
—
—
—
-1.0e+50
3.6e-01
6.3e-01
cases:1.01%
controls:1.38%
—
—
—
—
—
—
cases:0.00%
controls:0.07%
cases:0.81%
controls:0.56%
cases:4.05%
controls:2.20%
10
134
983
9592
—
—
—
0
7
996
9751
8
55
984
9682
39
208
924
9254
Urgent procedure
ZXD05 [2001311386]
2.3e-01
8.2e-01
—
—
—
8.2e-01
6.2e-01
cases:2.32%
controls:1.85%
cases:1.20%
controls:0.53%
—
—
—
—
—
—
cases:1.21%
controls:0.53%
cases:4.26%
controls:2.35%
23
180
970
9546
12
52
985
9708
—
—
—
12
52
980
9685
41
222
922
9240
paracetamol, combinations excl. psycholeptics
N02BE51 [21604348]
-2.1e-02
—
—
—
—
4.0e-01
6.1e-01
cases:2.01%
controls:2.06%
—
—
—
—
—
—
—
—
cases:1.01%
controls:0.68%
cases:4.57%
controls:2.53%
20
200
973
9526
—
—
—
—
10
66
982
9671
44
239
919
9223
piroxicam; ointment
M02AA07 [21604043]
6.0e-01
6.0e-01
—
—
-1.0e+50
5.0e-01
4.1e-01
cases:4.43%
controls:2.48%
cases:1.30%
controls:0.72%
—
—
—
—
cases:0.00%
controls:0.06%
cases:1.31%
controls:0.80%
cases:5.92%
controls:4.02%
44
241
949
9485
13
70
984
9690
—
—
0
6
996
9752
13
78
979
9659
57
380
906
9082
Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma
2324-2 [3026910]
2.6e-01
6.6e-01
—
—
—
3.7e-01
5.8e-01
cases:3.22%
controls:2.50%
cases:2.61%
controls:1.36%
—
—
—
—
—
—
cases:2.22%
controls:1.54%
cases:8.52%
controls:4.96%
32
243
961
9483
26
133
971
9627
—
—
—
22
150
970
9587
82
469
881
8993
Bilirubin.total [Moles/volume] in Serum or Plasma
14631-6 [3006140]
2.6e-01
7.0e-01
—
—
—
3.2e-01
5.8e-01
cases:2.11%
controls:1.63%
cases:1.81%
controls:0.90%
—
—
—
—
—
—
cases:1.21%
controls:0.88%
cases:4.36%
controls:2.49%
21
159
972
9567
18
88
979
9672
—
—
—
12
86
980
9651
42
236
921
9226
metronidazole; oral, rectal
P01AB01 [21604857]
2.6e-01
4.7e-01
—
—
—
5.8e-01
5.7e-01
cases:3.42%
controls:2.65%
cases:1.20%
controls:0.76%
—
—
—
—
—
—
cases:1.81%
controls:1.03%
cases:7.89%
controls:4.64%
34
258
959
9468
12
74
985
9686
—
—
—
18
100
974
9637
76
439
887
9023
Other and unspecified abdominal pain
R10.4 [45568113]
4.3e-01
2.4e-01
—
—
1.8e+00
3.4e-01
5.7e-01
cases:3.63%
controls:2.40%
cases:1.30%
controls:1.02%
—
—
—
—
cases:0.50%
controls:0.08%
cases:1.21%
controls:0.86%
cases:6.44%
controls:3.76%
36
233
957
9493
13
100
984
9660
—
—
5
8
991
9750
12
84
980
9653
62
356
901
9106
sulfadiazine and trimethoprim
J01EE02 [21602962]
1.4e-01
-3.9e-01
-1.0e+50
—
—
-2.8e-01
5.5e-01
cases:4.83%
controls:4.24%
cases:0.70%
controls:1.03%
cases:0.00%
controls:0.18%
—
—
—
—
cases:0.71%
controls:0.93%
cases:5.09%
controls:2.99%
48
412
945
9314
7
101
990
9659
0
18
997
9742
—
—
7
91
985
9646
49
283
914
9179
25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma
68438-1 [40771025]
-1.5e-01
-1.5e-01
—
—
1.4e+00
3.1e-01
5.4e-01
cases:1.31%
controls:1.52%
cases:1.10%
controls:1.28%
—
—
—
—
cases:0.60%
controls:0.14%
cases:1.81%
controls:1.34%
cases:5.40%
controls:3.22%
13
148
980
9578
11
125
986
9635
—
—
6
14
990
9744
18
130
974
9607
52
305
911
9157
prednisolone; oral, parenteral
H02AB06 [21602734]
2.0e-01
5.9e-01
-1.0e+50
—
—
2.3e-01
5.3e-01
cases:3.42%
controls:2.82%
cases:2.21%
controls:1.23%
cases:0.00%
controls:0.20%
—
—
—
—
cases:1.61%
controls:1.28%
cases:6.75%
controls:4.08%
34
274
959
9452
22
120
975
9640
0
20
997
9740
—
—
16
125
976
9612
65
386
898
9076
prednisolone
A07EA01 [21600653]
1.9e-01
5.9e-01
-1.0e+50
—
—
2.2e-01
5.3e-01
cases:3.42%
controls:2.85%
cases:2.21%
controls:1.24%
cases:0.00%
controls:0.20%
—
—
—
—
cases:1.61%
controls:1.30%
cases:6.75%
controls:4.10%
34
277
959
9449
22
121
975
9639
0
20
997
9740
—
—
16
127
976
9610
65
388
898
9074
betamethasone
S02BA07 [21605169]
5.3e-02
2.7e-01
—
—
—
5.3e-01
5.1e-01
cases:2.32%
controls:2.20%
cases:1.30%
controls:0.99%
—
—
—
—
—
—
cases:1.71%
controls:1.02%
cases:6.33%
controls:3.89%
23
214
970
9512
13
97
984
9663
—
—
—
17
99
975
9638
61
368
902
9094
betamethasone
C05AA05 [21601610]
5.3e-02
2.7e-01
—
—
—
5.3e-01
5.1e-01
cases:2.32%
controls:2.20%
cases:1.30%
controls:0.99%
—
—
—
—
—
—
cases:1.71%
controls:1.02%
cases:6.33%
controls:3.89%
23
214
970
9512
13
97
984
9663
—
—
—
17
99
975
9638
61
368
902
9094
betamethasone
A07EA04 [21600656]
5.3e-02
2.7e-01
—
—
—
5.3e-01
5.1e-01
cases:2.32%
controls:2.20%
cases:1.30%
controls:0.99%
—
—
—
—
—
—
cases:1.71%
controls:1.02%
cases:6.33%
controls:3.89%
23
214
970
9512
13
97
984
9663
—
—
—
17
99
975
9638
61
368
902
9094
betamethasone
D07AC01 [21602120]
5.3e-02
2.7e-01
—
—
—
5.3e-01
5.1e-01
cases:2.32%
controls:2.20%
cases:1.30%
controls:0.99%
—
—
—
—
—
—
cases:1.71%
controls:1.02%
cases:6.33%
controls:3.89%
23
214
970
9512
13
97
984
9663
—
—
—
17
99
975
9638
61
368
902
9094
hydrocortisone
S02BA01 [21605166]
2.1e-01
6.3e-01
—
—
—
-2.5e-02
5.0e-01
cases:5.34%
controls:4.39%
cases:2.71%
controls:1.47%
—
—
—
—
—
—
cases:1.61%
controls:1.65%
cases:8.72%
controls:5.46%
53
427
940
9299
27
143
970
9617
—
—
—
16
161
976
9576
84
517
879
8945
Normoblasts [#/volume] in Blood
715-3 [3021589]
-6.2e-01
-1.5e-01
—
—
9.3e-01
6.2e-01
5.0e-01
cases:1.51%
controls:2.77%
cases:1.81%
controls:2.09%
—
—
—
—
cases:1.10%
controls:0.44%
cases:3.23%
controls:1.77%
cases:5.82%
controls:3.60%
15
269
978
9457
18
204
979
9556
—
—
11
43
985
9715
32
172
960
9565
56
341
907
9121
pantoprazole; oral, parenteral
A02BC02 [21600097]
3.2e-01
3.0e-02
—
—
9.9e-01
5.3e-01
4.7e-01
cases:3.73%
controls:2.72%
cases:1.60%
controls:1.56%
—
—
—
—
cases:0.60%
controls:0.23%
cases:2.62%
controls:1.56%
cases:8.52%
controls:5.49%
37
265
956
9461
16
152
981
9608
—
—
6
22
990
9736
26
152
966
9585
82
519
881
8943
hydrocortisone
D07AA02 [21602102]
2.7e-01
6.3e-01
—
—
—
3.3e-02
4.7e-01
cases:6.04%
controls:4.66%
cases:3.11%
controls:1.68%
—
—
—
—
—
—
cases:1.81%
controls:1.76%
cases:9.35%
controls:6.05%
60
453
933
9273
31
164
966
9596
—
—
—
18
171
974
9566
90
572
873
8890
hydrocortisone buteprate
D07AB11 [21602115]
2.7e-01
6.3e-01
—
—
—
3.3e-02
4.7e-01
cases:6.04%
controls:4.66%
cases:3.11%
controls:1.68%
—
—
—
—
—
—
cases:1.81%
controls:1.76%
cases:9.35%
controls:6.05%
60
453
933
9273
31
164
966
9596
—
—
—
18
171
974
9566
90
572
873
8890
hydrocortisone butyrate
D07AB02 [21602106]
2.7e-01
6.3e-01
—
—
—
3.3e-02
4.7e-01
cases:6.04%
controls:4.66%
cases:3.11%
controls:1.68%
—
—
—
—
—
—
cases:1.81%
controls:1.76%
cases:9.35%
controls:6.05%
60
453
933
9273
31
164
966
9596
—
—
—
18
171
974
9566
90
572
873
8890
hydrocortisone aceponate
D07AC16 [21602135]
2.7e-01
6.3e-01
—
—
—
3.3e-02
4.7e-01
cases:6.04%
controls:4.66%
cases:3.11%
controls:1.68%
—
—
—
—
—
—
cases:1.81%
controls:1.76%
cases:9.35%
controls:6.05%
60
453
933
9273
31
164
966
9596
—
—
—
18
171
974
9566
90
572
873
8890
naproxen; oral, rectal
M01AE02 [21603968]
4.7e-01
3.6e-01
6.5e-01
—
8.6e-01
3.2e-01
3.3e-01
cases:11.28%
controls:7.37%
cases:4.01%
controls:2.83%
cases:0.70%
controls:0.37%
—
—
cases:0.70%
controls:0.30%
cases:3.93%
controls:2.90%
cases:13.40%
controls:10.04%
112
717
881
9009
40
276
957
9484
7
36
990
9724
—
7
29
989
9729
39
282
953
9455
129
950
834
8512
naproxcinod
M01AE18 [40254094]
4.7e-01
3.6e-01
6.5e-01
—
8.6e-01
3.2e-01
3.3e-01
cases:11.28%
controls:7.37%
cases:4.01%
controls:2.83%
cases:0.70%
controls:0.37%
—
—
cases:0.70%
controls:0.30%
cases:3.93%
controls:2.90%
cases:13.40%
controls:10.04%
112
717
881
9009
40
276
957
9484
7
36
990
9724
—
7
29
989
9729
39
282
953
9455
129
950
834
8512
hydrocortisone
C05AA01 [21601608]
2.8e-01
6.2e-01
—
—
—
2.7e-02
4.5e-01
cases:6.14%
controls:4.70%
cases:3.11%
controls:1.69%
—
—
—
—
—
—
cases:1.81%
controls:1.77%
cases:9.35%
controls:6.18%
61
457
932
9269
31
165
966
9595
—
—
—
18
172
974
9565
90
585
873
8877
hydrocortisone
A07EA02 [21600654]
2.8e-01
6.2e-01
—
—
—
2.7e-02
4.5e-01
cases:6.14%
controls:4.70%
cases:3.11%
controls:1.69%
—
—
—
—
—
—
cases:1.81%
controls:1.77%
cases:9.35%
controls:6.18%
61
457
932
9269
31
165
966
9595
—
—
—
18
172
974
9565
90
585
873
8877
Orthopedic Surgery
20 [38004465]
1.4e-01
4.7e-01
1.0e+00
—
1.2e+00
6.6e-01
4.2e-01
cases:4.13%
controls:3.60%
cases:2.61%
controls:1.65%
cases:0.60%
controls:0.22%
—
—
cases:0.80%
controls:0.24%
cases:3.13%
controls:1.64%
cases:9.87%
controls:6.73%
41
350
952
9376
26
161
971
9599
6
21
991
9739
—
8
23
988
9735
31
160
961
9577
95
637
868
8825
diclofenac; oral, parenteral, rectal
M01AB05 [21603945]
4.1e-01
4.1e-01
-1.0e+50
—
—
2.9e-01
2.5e-01
cases:8.96%
controls:6.12%
cases:3.51%
controls:2.37%
cases:0.00%
controls:0.34%
—
—
—
—
cases:3.53%
controls:2.66%
cases:13.19%
controls:10.60%
89
595
904
9131
35
231
962
9529
0
33
997
9727
—
—
35
259
957
9478
127
1003
836
8459
benzathine phenoxymethylpenicillin; oral
J01CE10 [21602850]
1.7e-01
2.1e-01
—
—
—
2.6e-01
4.1e-01
cases:11.98%
controls:10.27%
cases:4.01%
controls:3.28%
—
—
—
—
—
—
cases:3.93%
controls:3.06%
cases:18.48%
controls:13.06%
119
999
874
8727
40
320
957
9440
—
—
—
39
298
953
9439
178
1236
785
8226
phenoxymethylpenicillin; oral
J01CE02 [21602842]
1.7e-01
2.1e-01
—
—
—
2.6e-01
4.1e-01
cases:11.98%
controls:10.27%
cases:4.01%
controls:3.28%
—
—
—
—
—
—
cases:3.93%
controls:3.06%
cases:18.48%
controls:13.06%
119
999
874
8727
40
320
957
9440
—
—
—
39
298
953
9439
178
1236
785
8226
Thyrotropin [Units/volume] in Serum or Plasma
3016-3 [3009201]
2.0e-03
2.6e-01
1.1e-01
—
7.4e-01
2.8e-01
3.9e-01
cases:4.93%
controls:4.92%
cases:3.81%
controls:2.96%
cases:0.50%
controls:0.45%
—
—
cases:0.70%
controls:0.34%
cases:4.13%
controls:3.14%
cases:13.50%
controls:9.55%
49
479
944
9247
38
289
959
9471
5
44
992
9716
—
7
33
989
9725
41
306
951
9431
130
904
833
8558
combinations of corticosteroids
D07XB30 [21602188]
1.4e-01
7.6e-02
—
—
—
3.3e-01
3.7e-01
cases:6.24%
controls:5.46%
cases:2.21%
controls:2.05%
—
—
—
—
—
—
cases:2.82%
controls:2.05%
cases:11.32%
controls:8.12%
62
531
931
9195
22
200
975
9560
—
—
—
28
200
964
9537
109
768
854
8694
combinations of corticosteroids
D07AB30 [21602118]
1.4e-01
7.6e-02
—
—
—
3.3e-01
3.7e-01
cases:6.24%
controls:5.46%
cases:2.21%
controls:2.05%
—
—
—
—
—
—
cases:2.82%
controls:2.05%
cases:11.32%
controls:8.12%
62
531
931
9195
22
200
975
9560
—
—
—
28
200
964
9537
109
768
854
8694
Telehealth
OMOP5556618 [722455]
1.7e-01
2.5e-01
6.2e-01
—
8.6e-01
4.3e-01
3.6e-01
cases:9.37%
controls:8.02%
cases:4.61%
controls:3.65%
cases:1.00%
controls:0.54%
—
—
cases:1.20%
controls:0.51%
cases:5.54%
controls:3.69%
cases:12.88%
controls:9.37%
93
780
900
8946
46
356
951
9404
10
53
987
9707
—
12
50
984
9708
55
359
937
9378
124
887
839
8575
paracetamol; oral, parenteral, rectal
N02BE01 [21604344]
2.2e-01
3.6e-01
-3.8e-02
—
8.6e-01
4.1e-01
3.4e-01
cases:9.67%
controls:7.89%
cases:5.32%
controls:3.76%
cases:0.60%
controls:0.63%
—
—
cases:1.10%
controls:0.47%
cases:5.95%
controls:4.05%
cases:18.17%
controls:13.68%
96
767
897
8959
53
367
944
9393
6
61
991
9699
—
11
46
985
9712
59
394
933
9343
175
1294
788
8168
amoxicillin; oral, parenteral
J01CA04 [21602823]
1.2e-01
-1.0e-02
1.0e-01
—
3.7e-01
3.2e-01
3.2e-01
cases:20.44%
controls:18.59%
cases:6.02%
controls:6.08%
cases:0.60%
controls:0.54%
—
—
cases:1.00%
controls:0.70%
cases:7.96%
controls:5.90%
cases:24.92%
controls:19.45%
203
1808
790
7918
60
593
937
9167
6
53
991
9707
—
10
68
986
9690
79
574
913
9163
240
1840
723
7622
cefalexin; oral
J01DB01 [21602870]
2.1e-01
-1.6e-02
2.5e-01
—
2.2e-01
3.6e-01
3.0e-01
cases:21.45%
controls:18.15%
cases:6.22%
controls:6.31%
cases:0.90%
controls:0.71%
—
—
cases:0.80%
controls:0.65%
cases:9.27%
controls:6.68%
cases:29.70%
controls:23.82%
213
1765
780
7961
62
616
935
9144
9
69
988
9691
—
8
63
988
9695
92
650
900
9087
286
2254
677
7208
ibuprofen
R02AX02 [1588667]
1.5e-01
3.5e-01
3.5e-01
—
4.2e-01
3.6e-01
2.6e-01
cases:16.62%
controls:14.63%
cases:9.23%
controls:6.68%
cases:1.20%
controls:0.85%
—
—
cases:1.41%
controls:0.93%
cases:10.48%
controls:7.55%
cases:28.35%
controls:23.40%
165
1423
828
8303
92
652
905
9108
12
83
985
9677
—
14
91
982
9667
104
735
888
9002
273
2214
690
7248
ibuprofen; oral, parenteral, rectal
M01AE01 [21603967]
1.5e-01
3.5e-01
3.5e-01
—
4.2e-01
3.6e-01
2.6e-01
cases:16.62%
controls:14.63%
cases:9.23%
controls:6.68%
cases:1.20%
controls:0.85%
—
—
cases:1.41%
controls:0.93%
cases:10.48%
controls:7.55%
cases:28.35%
controls:23.40%
165
1423
828
8303
92
652
905
9108
12
83
985
9677
—
14
91
982
9667
104
735
888
9002
273
2214
690
7248
loratadine; oral
R06AX13 [21603514]
4.9e-02
1.6e-01
—
—
-1.0e+50
7.4e-02
9.0e-02
cases:1.51%
controls:1.44%
cases:0.80%
controls:0.69%
—
—
—
—
cases:0.00%
controls:0.13%
cases:0.81%
controls:0.75%
cases:2.08%
controls:1.90%
15
140
978
9586
8
67
989
9693
—
—
0
13
996
9745
8
73
984
9664
20
180
943
9282
Vestibular neuronitis
H81.2 [45562323]
—
—
—
—
—
—
-1.0e+50
—
—
—
—
—
—
—
—
—
—
—
—
cases:0.00%
controls:0.10%
—
—
—
—
—
—
0
9
963
9453
Malignant tumor of the upper outer quadrant of the mammary gland, no histological veryfication
C50.40 [2000501001]
—
—
—
—
—
—
-1.0e+50
—
—
—
—
—
—
—
—
—
—
—
—
cases:0.00%
controls:0.05%
—
—
—
—
—
—
0
5
963
9457
Circumcisio
7542 [2000101270]
-1.0e+50
—
—
—
—
—
—
cases:0.00%
controls:0.06%
—
—
—
—
—
—
—
—
—
—
—
—
0
6
993
9720
—
—
—
—
—
—
Fear of respiratory disease other
R27 [2002000896]
—
—
—
—
—
—
-1.0e+50
—
—
—
—
—
—
—
—
—
—
—
—
cases:0.00%
controls:0.05%
—
—
—
—
—
—
0
5
963
9457
Cardiodefibrillation
TFP20 [2001303224]
-1.0e+50
—
—
—
—
—
—
cases:0.00%
controls:0.07%
—
—
—
—
—
—
—
—
—
—
—
—
0
7
993
9719
—
—
—
—
—
—
Mild depressive episode with somatic syndrome
F32.01 [2000501979]
—
—
—
—
—
—
-1.0e+50
—
—
—
—
—
—
—
—
—
—
—
—
cases:0.00%
controls:0.06%
—
—
—
—
—
—
0
6
963
9456
Superficial injury of scalp
S00.0 [45548998]
-1.0e+50
—
—
—
—
—
—
cases:0.00%
controls:0.05%
—
—
—
—
—
—
—
—
—
—
—
—
0
5
993
9721
—
—
—
—
—
—
Vibrio sp identified in Specimen by Organism specific culture
6581-3 [3005988]
-1.0e+50
—
—
—
—
—
-1.0e+50
cases:0.00%
controls:0.05%
—
—
—
—
—
—
—
—
—
—
cases:0.00%
controls:0.07%
0
5
993
9721
—
—
—
—
—
0
7
963
9455
Nonallergic asthma
J45.1 [45557625]
-5.2e-01
—
-1.0e+50
—
-1.0e+50
—
—
cases:0.50%
controls:0.84%
—
—
cases:0.00%
controls:0.07%
—
—
cases:0.00%
controls:0.07%
—
—
—
—
5
82
988
9644
—
0
7
997
9753
—
0
7
996
9751
—
—
Dental dislocation
S03.20 [2000503631]
—
—
—
—
—
—
-1.0e+50
—
—
—
—
—
—
—
—
—
—
—
—
cases:0.00%
controls:0.12%
—
—
—
—
—
—
0
11
963
9451
Sterilization of the laparotomy pathway
8221 [2000101311]
—
—
—
—
—
—
-1.0e+50
—
—
—
—
—
—
—
—
—
—
—
—
cases:0.00%
controls:0.05%
—
—
—
—
—
—
0
5
963
9457
X-ray of knees
NG1DA [2001308067]
—
—
—
—
—
—
-1.0e+50
—
—
—
—
—
—
—
—
—
—
—
—
cases:0.00%
controls:0.11%
—
—
—
—
—
—
0
10
963
9452
Change in the oral mucosa UNS
K13.79 [2000502894]
—
—
—
—
—
—
-1.0e+50
—
—
—
—
—
—
—
—
—
—
—
—
cases:0.00%
controls:0.06%
—
—
—
—
—
—
0
6
963
9456
clindamycin; vaginal
G01AA10 [21602372]
1.5e-01
4.5e-01
—
—
—
2.1e-01
4.8e-01
cases:2.11%
controls:1.82%
cases:0.70%
controls:0.45%
—
—
—
—
—
—
cases:0.71%
controls:0.58%
cases:3.84%
controls:2.41%
21
177
972
9549
7
44
990
9716
—
—
—
7
56
985
9681
37
228
926
9234
Disorder of ligament
M24.2 [45557839]
—
—
—
—
—
—
-1.0e+50
—
—
—
—
—
—
—
—
—
—
—
—
cases:0.00%
controls:0.06%
—
—
—
—
—
—
0
6
963
9456
Aortic (valve) insufficiency
I35.1 [45572087]
—
—
—
—
—
-1.0e+50
—
—
—
—
—
—
—
—
—
—
—
cases:0.00%
controls:0.08%
—
—
—
—
—
—
—
0
8
992
9729
—
candesartan; oral
C09CA06 [21601829]
2.0e-01
-1.3e-01
7.2e-01
—
—
6.3e-02
3.1e-01
cases:1.01%
controls:0.82%
cases:0.70%
controls:0.80%
cases:0.50%
controls:0.25%
—
—
—
—
cases:0.91%
controls:0.85%
cases:2.08%
controls:1.53%
10
80
983
9646
7
78
990
9682
5
24
992
9736
—
—
9
83
983
9654
20
145
943
9317
Nail symptom/complaint
S22 [2002000987]
—
—
—
—
—
-1.0e+50
—
—
—
—
—
—
—
—
—
—
—
cases:0.00%
controls:0.06%
—
—
—
—
—
—
—
0
6
992
9731
—
Paediatric Clinical Immunology and Allergy
255 [44777768]
-5.4e-02
—
-1.0e+50
—
-1.0e+50
—
—
cases:0.60%
controls:0.64%
—
—
cases:0.00%
controls:0.09%
—
—
cases:0.00%
controls:0.06%
—
—
—
—
6
62
987
9664
—
0
9
997
9751
—
0
6
996
9752
—
—
Other and unspecified infectious diseases
B99 [45590874]
-1.0e+50
—
—
—
—
—
—
cases:0.00%
controls:0.06%
—
—
—
—
—
—
—
—
—
—
—
—
0
6
993
9720
—
—
—
—
—
—
Respiratory symptom/complaint other
R29 [2002000898]
—
—
—
—
—
-1.0e+50
8.1e-01
—
—
—
—
—
—
—
—
—
—
cases:0.00%
controls:0.13%
cases:0.52%
controls:0.23%
—
—
—
—
—
0
13
992
9724
5
22
958
9440
Idiopathic proctocolitis, Ulcerative (chronic) ileocolitis
5561A [2000404402]
—
—
—
—
—
—
-1.0e+50
—
—
—
—
—
—
—
—
—
—
—
—
cases:0.00%
controls:0.06%
—
—
—
—
—
—
0
6
963
9456
warfarin; oral, parenteral
B01AA03 [21600965]
1.5e-01
3.1e-01
—
—
—
4.3e-01
5.1e-01
cases:0.91%
controls:0.78%
cases:0.90%
controls:0.67%
—
—
—
—
—
—
cases:1.01%
controls:0.66%
cases:2.08%
controls:1.26%
9
76
984
9650
9
65
988
9695
—
—
—
10
64
982
9673
20
119
943
9343
Cone beam imaging of teeth and jaws (1–2 quarters)
EB1BI [2001301908]
—
—
—
—
—
—
-1.0e+50
—
—
—
—
—
—
—
—
—
—
—
—
cases:0.00%
controls:0.12%
—
—
—
—
—
—
0
11
963
9451
Procreative investigation and testing
Z31.4 [45566416]
—
—
—
—
—
—
-1.0e+50
—
—
—
—
—
—
—
—
—
—
—
—
cases:0.00%
controls:0.11%
—
—
—
—
—
—
0
10
963
9452
Taking care of patient’s/customer’s hygiene
SPAT1137 [2001700238]
-1.0e+50
-1.0e+50
—
—
—
—
-1.0e+50
cases:0.00%
controls:0.06%
cases:0.00%
controls:0.06%
—
—
—
—
—
—
—
—
cases:0.00%
controls:0.08%
0
6
993
9720
0
6
997
9754
—
—
—
—
0
8
963
9454
Rhinopharyngoscopy
UDH02 [2001301680]
—
—
—
—
—
-1.0e+50
1.0e+00
—
—
—
—
—
—
—
—
—
—
cases:0.00%
controls:0.06%
cases:0.52%
controls:0.19%
—
—
—
—
—
0
6
992
9731
5
18
958
9444
Microscopic observation [Identifier] in Isolate by Gram stain
87975-9 [36305247]
-1.0e+50
—
—
—
—
-1.0e+50
—
cases:0.00%
controls:0.07%
—
—
—
—
—
—
—
—
cases:0.00%
controls:0.06%
—
—
0
7
993
9719
—
—
—
—
0
6
992
9731
—
etodolac; oral
M01AB08 [21603948]
—
-1.0e+50
—
—
—
—
3.9e-01
—
—
cases:0.00%
controls:0.06%
—
—
—
—
—
—
—
—
cases:0.62%
controls:0.42%
—
0
6
997
9754
—
—
—
—
6
40
957
9422
Cholecystectomy
6662 [2000101065]
-1.0e+50
—
—
—
—
—
—
cases:0.00%
controls:0.07%
—
—
—
—
—
—
—
—
—
—
—
—
0
7
993
9719
—
—
—
—
—
—
proguanil and atovaquone
P01BB51 [21604895]
-1.0e+50
—
—
—
—
—
—
cases:0.00%
controls:0.06%
—
—
—
—
—
—
—
—
—
—
—
—
0
6
993
9720
—
—
—
—
—
—
Bacteria identified in Skin by Aerobe culture
620-5 [3007853]
4.9e-02
—
-1.0e+50
—
—
—
-2.7e-01
cases:0.60%
controls:0.58%
—
—
cases:0.00%
controls:0.05%
—
—
—
—
—
—
cases:0.62%
controls:0.81%
6
56
987
9670
—
0
5
997
9755
—
—
—
6
77
957
9385
Progesterone [Moles/volume] in Serum or Plasma
14890-8 [3005082]
-1.0e+50
—
—
—
—
—
—
cases:0.00%
controls:0.05%
—
—
—
—
—
—
—
—
—
—
—
—
0
5
993
9721
—
—
—
—
—
—
Labour and delivery complicated by fetal heart rate anomaly with meconium in amniotic fluid
O68.2 [45572879]
—
—
—
—
—
—
-1.0e+50
—
—
—
—
—
—
—
—
—
—
—
—
cases:0.00%
controls:0.05%
—
—
—
—
—
—
0
5
963
9457
Examination of ears and hearing
Z01.1 [45547279]
1.7e-01
5.6e-01
—
—
—
—
-2.5e-01
cases:1.01%
controls:0.85%
cases:0.50%
controls:0.29%
—
—
—
—
—
—
—
—
cases:0.52%
controls:0.67%
10
83
983
9643
5
28
992
9732
—
—
—
—
5
63
958
9399
Excision of preretinal or epiretinal membrane
CKD70 [2001301418]
—
—
—
—
—
—
-1.0e+50
—
—
—
—
—
—
—
—
—
—
—
—
cases:0.00%
controls:0.05%
—
—
—
—
—
—
0
5
963
9457
Inguinal hernia, without mention of obstruction or gangrene[HERNIA INGUINALIS SINE GANGR/OBSTR,MEDIALIS]
5509A [2000404363]
—
—
—
—
—
—
-1.0e+50
—
—
—
—
—
—
—
—
—
—
—
—
cases:0.00%
controls:0.06%
—
—
—
—
—
—
0
6
963
9456

LabWAS

↥
OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
cases
controls
unit
-log10(p)
N cases
N controls
308
121
33.17
307.65
5.1
6.6
391.82
360.12
umol/l
1.45
283
108
83
27
32.80
128.02
3.2
1.7
18.12
14.77
umol/l
1.12
83
27
514
2790
2.40
48.43
3.0
2.0
170.00
213.43
u/l
0.91
503
2666
621
4233
1.90
27.64
6.3
7.5
1.21
1.21
mmol/l
2.23
589
3946
679
4788
1.89
26.97
7.0
7.7
1.21
1.21
mmol/l
1.44
594
4189
73
206
3.70
22.44
2.7
3.9
33.40
33.76
umol/l
0.05
67
191
777
5975
1.76
20.81
5.5
5.4
6.54
6.49
mmol/l
0.21
730
5558
393
2773
1.60
12.69
3.9
4.0
7.40
7.40
ph
0.43
295
1945
184
1057
1.86
12.57
4.3
6.2
7.37
7.38
ph
0.36
113
630
434
3157
1.57
12.21
2.6
2.6
54.49
60.71
u/l
1.39
403
2957
548
4222
1.52
11.74
5.3
5.3
36.03
36.75
g/l
2.22
517
3982
656
5270
1.50
11.36
7.1
7.0
0.67
0.68
%
0.09
624
4973
719
5897
1.50
11.18
7.6
7.2
0.18
0.19
e9/l
0.62
637
5198
665
5369
1.49
11.16
6.7
6.8
53.82
56.01
%
5.22
638
5172
700
5711
1.50
11.16
6.9
6.9
0.04
0.04
e9/l
0.51
611
4956
698
5700
1.49
11.02
6.8
6.9
0.58
0.56
e9/l
1.20
610
4945
655
5285
1.49
10.95
7.2
7.1
8.84
8.55
%
1.79
623
5005
654
5276
1.49
10.94
7.0
7.0
2.64
2.86
%
1.73
623
4986
178
1060
1.79
10.75
4.2
6.1
5.75
5.81
kpa
0.34
168
1031
711
5847
1.48
10.71
6.9
6.9
2.04
1.98
e9/l
0.80
629
5213
671
5456
1.48
10.69
7.1
7.0
31.36
29.39
%
4.58
645
5223
173
1029
1.79
10.48
4.2
6.2
1.16
1.54
mmol/l
0.62
146
873
244
1598
1.65
10.41
3.1
4.4
0.82
0.82
mmol/l
0.28
232
1525
495
3824
1.48
10.01
4.0
3.5
28.73
31.41
u/l
1.09
470
3641
161
968
1.76
9.37
7.0
10.0
7.41
7.41
ph
0.12
95
530
259
1768
1.58
9.24
4.0
3.5
207.00
602.67
ng/l
2.21
174
1173
747
6303
1.44
9.20
10.6
9.7
3.90
4.01
e9/l
0.58
648
5502
448
3442
1.46
9.11
3.8
3.2
28.85
64.06
ng/l
0.98
263
2033
335
2451
1.50
8.64
5.4
4.2
—
—
—
0
0
154
944
1.72
8.36
2.0
2.8
0.22
0.22
g/l
0.21
148
895
422
3262
1.44
8.11
5.9
6.3
—
—
—
0
0
202
1340
1.60
8.06
1.8
1.7
1124.64
1146.44
nmol/l
0.12
161
1034
154
956
1.69
7.97
7.2
10.1
1.18
0.78
mmol/l
0.49
127
790
882
7775
1.43
7.87
7.9
7.6
77.58
79.47
u/l
0.81
827
7404
519
4183
1.40
7.81
2.1
1.9
95.54
96.70
pmol/l
0.22
279
2295
627
5227
1.39
7.68
6.0
6.4
9.21
12.01
umol/l
5.10
596
4971
502
4039
1.40
7.56
13.2
10.9
1.19
1.17
inr
0.22
423
3344
140
875
1.67
7.06
5.5
10.6
1.43
1.33
mmol/l
0.53
140
852
1133
10574
1.61
6.94
19.8
14.7
139.00
139.64
mmol/l
10.86
1107
10381
22
62
3.59
6.88
2.2
4.3
206.00
144.97
umol/l
0.29
12
35
157
1020
1.61
6.80
2.7
2.4
33.98
41.50
u/l
0.59
141
849
338
2581
1.42
6.73
3.8
3.5
1.02
1.61
kg/l
0.50
234
1694
144
924
1.63
6.56
3.5
5.7
4.76
4.70
kpa
0.10
136
898
340
2615
1.41
6.47
1.8
1.6
20.53
20.19
nmol/l
0.15
303
2295
420
3347
1.38
6.47
2.6
3.2
2.34
2.36
mmol/l
1.88
386
3100
384
4743
0.73
6.17
2.8
2.7
—
—
—
0
0
96
564
1.76
6.07
2.7
3.1
112.30
156.47
ng/l
0.93
89
506
26
89
2.96
6.02
3.0
2.0
—
—
—
0
0
72
388
1.91
6.01
2.9
2.6
—
—
—
0
0
1129
10598
1.54
5.94
19.6
14.8
3.97
3.94
mmol/l
2.30
1103
10380
363
2858
1.38
5.93
3.5
2.7
—
—
—
0
0
193
1360
1.49
5.80
4.0
3.2
3.79
5.16
e9/l
2.15
166
1229
138
913
1.57
5.54
6.9
11.5
—
—
—
0
0
102
628
1.68
5.47
3.2
2.8
—
—
—
0
0
52
260
2.04
5.39
8.5
6.9
1.48
1.21
mmol/l
1.03
44
225
93
1462
0.61
5.12
2.5
2.8
0.66
0.76
ug/l
0.57
58
822
34
147
2.35
5.04
1.7
1.6
61.63
67.77
mmol/l
0.31
27
123
57
308
1.89
4.77
2.2
1.8
0.90
2.26
ug/l
0.76
48
271
108
704
1.58
4.64
2.4
2.1
—
—
—
0
0
569
4911
1.28
4.62
2.6
2.6
73.64
73.70
nmol/l
0.02
520
4591
311
2485
1.33
4.45
1.7
2.0
1.42
1.11
mg/l
0.32
230
1891
36
171
2.14
4.31
4.1
3.0
2.47
2.36
mmol/l
0.08
26
105
48
254
1.92
4.30
1.2
1.9
5.33
16.37
e6/l
1.28
36
193
76
464
1.68
4.26
6.6
5.1
—
—
—
0
0
48
256
1.91
4.21
1.1
1.8
3.96
3.60
mmol/l
1.07
48
245
46
242
1.93
4.20
1.2
1.9
—
—
—
0
0
115
782
1.52
4.12
3.9
3.9
7.37
7.35
ph
1.01
89
572
48
259
1.89
4.08
1.2
1.9
1401.78
1484.80
e6/l
0.02
37
203
158
1149
1.43
4.03
1.7
2.2
392.54
376.44
nmol/l
0.44
148
1081
766
6945
1.26
3.83
5.1
4.2
527.27
1231.24
e6/l
0.52
15
98
125
880
1.47
3.79
2.5
2.0
—
—
—
0
0
976
10329
0.77
3.75
4.5
4.4
1.45
1.45
mmol/l
0.02
924
9819
338
2790
1.29
3.74
2.3
2.3
2.63
2.69
mg/l
0.20
293
2424
125
885
1.46
3.69
2.5
2.0
—
—
—
0
0
125
890
1.45
3.59
2.5
2.0
—
—
—
0
0
982
10368
0.78
3.55
4.7
4.5
4.70
4.68
mmol/l
0.16
938
9908
117
825
1.46
3.53
2.6
2.0
—
—
—
0
0
992
10451
0.78
3.44
5.2
4.9
2.78
2.79
mmol/l
0.18
942
9946
123
881
1.44
3.43
2.5
1.9
—
—
—
0
0
920
9773
0.79
3.37
3.9
3.8
1.33
1.26
mmol/l
1.72
865
9244
111
787
1.45
3.27
3.7
5.8
5.14
5.11
kpa
0.24
105
762
103
1435
0.69
3.19
1.2
1.3
—
—
—
0
0
215
1706
1.31
3.18
1.3
1.4
443.16
510.03
titre
0.19
38
337
108
767
1.45
3.16
3.7
5.9
7.41
7.41
ph
0.61
77
626
180
1397
1.34
3.11
2.5
2.6
23.91
23.68
%
0.08
167
1318
168
1292
1.35
3.08
1.8
1.6
—
—
—
0
0
353
4117
0.80
3.06
2.0
2.0
—
—
—
0
0
87
602
1.48
2.93
1.7
1.7
0.25
0.31
mg/l
0.52
39
275
137
1033
1.37
2.86
3.0
3.6
1.88
1.72
%
0.99
125
938
58
369
1.60
2.85
1.1
1.1
1.13
7.18
eliau/ml
—
10
59
176
1380
1.32
2.84
5.8
7.3
1.10
1.09
mmol/l
0.16
162
1298
279
2325
1.26
2.79
2.7
3.3
744.89
1054.37
ng/l
1.40
231
1933
113
832
1.39
2.74
2.3
2.3
7827.14
6423.30
u/l
0.15
47
354
385
3334
1.22
2.69
3.7
3.6
7.55
8.13
mmol/l
1.38
331
2928
207
1677
1.28
2.62
2.5
2.6
13.92
14.22
umol/l
0.22
195
1573
91
1249
0.71
2.61
1.5
1.6
3.71
3.45
mmol/l
1.38
57
850
193
1554
1.28
2.56
2.5
2.5
2.37
2.39
g/l
0.19
181
1444
20
94
2.15
2.55
1.8
1.7
90.53
91.14
%
0.23
20
94
45
277
1.65
2.55
2.7
2.9
5.57
2.59
index
0.42
21
156
16
69
2.34
2.49
1.2
1.1
—
—
—
0
0
229
1891
1.26
2.47
1.7
1.7
435.76
39082995.82
pmol/l
2.41
191
1635
838
7839
1.20
2.47
4.2
3.3
49.93
40.34
u/l
3.57
811
7514
24
123
1.97
2.46
1.2
1.3
—
—
—
0
0
69
475
1.48
2.42
1.3
1.2
0.22
1.13
u/ml
—
5
29
24
124
1.95
2.41
1.1
2.1
—
—
—
0
0
338
2926
1.21
2.33
3.4
3.1
—
1.00
—
0
8
6
13
4.63
2.27
1.2
1.5
—
—
—
0
0
51
338
1.53
2.17
1.3
1.3
17.54
10.83
u/ml
—
8
44
19
94
2.04
2.16
1.4
2.4
—
—
—
0
0
7
19
3.70
2.15
1.3
1.3
—
—
—
0
0
228
1916
1.23
2.11
2.7
2.8
534.93
536.55
mosm/kgh2o
0.03
205
1682
210
1755
1.24
2.04
1.7
1.6
—
—
—
0
0
202
2406
0.81
2.04
3.6
4.7
1.39
2.17
ug/l
3.05
185
2191
38
587
0.64
2.04
1.1
1.2
0.86
0.89
g/l
0.42
38
587
82
604
1.38
2.04
2.0
1.8
—
—
—
0
0
53
764
0.68
2.04
1.5
1.5
—
—
—
0
0
104
796
1.33
2.03
2.3
2.4
17.35
19.40
au/ml
—
6
102
68
488
1.42
1.97
1.9
2.0
10.51
6.85
iu/ml
0.51
13
108
300
2607
1.20
1.97
4.1
4.4
95.81
92.09
%
1.98
294
2550
34
210
1.64
1.96
1.1
1.1
59.29
2437.31
iu/ml
—
7
54
78
575
1.38
1.94
4.2
6.3
—
—
—
0
0
38
575
0.65
1.87
1.0
1.1
1.52
1.53
g/l
0.09
38
575
549
5033
1.16
1.85
10.4
10.7
0.00
0.00
e9/l
0.70
420
4088
12
250
0.48
1.85
1.2
1.3
—
—
—
0
0
24
138
1.75
1.80
3.6
3.3
0.58
1.29
%
1.09
19
129
117
931
1.28
1.75
1.8
2.1
0.00
0.02
estimate
0.78
28
225
114
905
1.28
1.74
5.1
5.0
0.67
0.92
%
0.67
44
259
11
48
2.30
1.70
1.6
1.3
—
—
—
0
0
1174
11968
0.78
1.70
28.3
20.3
6.80
6.74
e9/l
0.42
1154
11736
94
732
1.31
1.66
3.2
4.7
93.67
79.08
ng/l
0.55
78
667
6
19
3.17
1.66
2.0
1.3
—
—
—
0
0
133
1615
0.80
1.62
1.6
1.9
3.70
3.48
ratio
0.97
97
1211
1175
11970
0.78
1.61
28.4
20.4
134.64
136.27
g/l
3.76
1168
11883
8
32
2.51
1.60
2.9
2.2
—
—
—
0
0
26
159
1.65
1.59
1.7
1.6
—
—
—
0
0
1113
10824
1.21
1.57
18.3
13.3
22.33
21.89
mg/l
0.17
946
8723
515
4744
1.14
1.56
3.2
3.2
6.45
6.20
ph
5.52
298
2692
83
643
1.31
1.54
1.3
1.2
—
—
—
0
0
1175
11964
0.79
1.53
28.1
20.1
30.32
30.10
pg
4.21
1168
11878
1175
11964
0.79
1.53
28.7
20.7
39.96
40.62
%
4.56
1168
11872
1175
11964
0.79
1.53
28.2
20.2
4.47
4.56
e12/l
8.32
1156
11743
57
418
1.38
1.51
1.6
1.3
—
—
—
0
0
157
1317
1.22
1.51
1.4
1.4
—
—
—
0
0
6
21
2.87
1.50
1.0
1.3
—
—
—
0
0
1156
11293
1.24
1.50
12.8
10.6
25.52
26.58
u/l
1.36
1125
11049
1175
11961
0.79
1.49
28.1
20.1
90.45
90.09
fl
1.92
1168
11877
12
58
2.08
1.49
1.2
1.3
—
—
—
0
0
48
343
1.41
1.48
1.1
1.3
80.00
91.00
titre
—
5
40
22
132
1.68
1.46
1.0
1.2
2.79
3.22
u/ml
—
7
61
95
756
1.28
1.46
2.7
3.5
69.69
70.40
e9/l
0.07
75
528
1175
11957
0.80
1.44
28.3
20.2
249.87
256.85
e9/l
3.38
1155
11757
5
16
3.13
1.44
1.6
1.1
—
—
—
0
0
107
1311
0.80
1.43
1.3
1.2
—
—
—
0
0
22
133
1.67
1.43
1.1
2.5
—
—
—
0
0
87
688
1.28
1.41
4.0
3.5
1.22
1.23
mmol/l
0.59
78
585
7
29
2.42
1.39
1.6
1.1
—
0.52
—
0
5
902
8658
1.14
1.37
4.9
4.4
14.14
14.53
pmol/l
5.22
847
8094
56
418
1.36
1.36
2.1
1.7
—
—
—
0
0
35
241
1.46
1.33
2.6
3.4
43.00
67.28
mg/l
0.45
27
208
35
241
1.46
1.33
2.6
3.4
34.13
33.94
mg/l
0.01
28
207
25
160
1.57
1.32
1.1
1.4
—
11.68
—
0
5
430
3951
1.13
1.32
3.5
3.9
68.27
75.45
e6/l
0.13
297
2636
621
5836
1.12
1.31
4.0
3.5
16.63
3.84
estimate
0.35
121
1184
6
24
2.51
1.30
4.0
4.0
54.25
50.13
%
—
6
24
49
361
1.37
1.30
1.2
1.2
—
—
—
0
0
5
18
2.78
1.28
1.0
1.1
70.40
64.00
titre
—
5
18
189
1640
1.18
1.28
2.4
3.0
6.31
2.78
e6/l
1.50
99
794
60
777
0.76
1.27
1.4
1.7
—
—
—
0
0
131
1100
1.21
1.27
1.2
1.2
—
—
—
0
0
123
1027
1.22
1.26
1.3
1.3
94.48
144.04
u/ml
0.70
39
418
298
2680
1.15
1.26
1.8
1.8
—
—
—
0
0
19
115
1.66
1.25
2.3
3.6
—
—
—
0
0
201
1757
1.17
1.25
2.4
2.6
2.42
2.43
mmol/l
0.43
181
1569
358
3262
1.14
1.25
2.9
3.3
75.82
76.29
e6/l
0.00
282
2446
6
25
2.41
1.24
2.7
1.7
41.92
43.22
g/l
—
6
25
29
196
1.49
1.22
1.9
1.6
738.50
337.61
mu/l
1.28
24
166
350
3189
1.13
1.22
1.4
1.4
2.24
1.65
u/ml
0.32
85
867
32
221
1.46
1.22
1.0
1.1
—
—
—
0
0
31
213
1.47
1.21
2.2
3.2
1.33
2.18
ratio
1.02
14
122
49
366
1.35
1.21
1.9
2.3
1.31
1.38
g/l
0.16
42
331
103
1239
0.82
1.19
1.6
1.4
—
—
—
0
0
105
869
1.23
1.18
5.0
4.8
0.48
0.66
%
0.60
42
244
8
38
2.11
1.18
1.0
1.6
69.50
82.08
nmol/24h
—
8
38
1034
10051
1.15
1.18
6.0
5.2
1.88
1.83
mu/l
0.84
982
9522
53
403
1.33
1.17
1.1
1.1
5.85
6.32
u/ml
0.07
25
251
10
51
1.97
1.11
2.3
3.4
—
—
—
0
0
10
51
1.97
1.11
2.0
3.2
7.63
8.36
mmol/l
—
10
51
10
181
0.55
1.09
1.6
1.6
—
—
—
0
0
9
162
0.55
1.09
1.4
1.4
—
—
—
0
0
32
227
1.42
1.08
1.1
1.1
—
—
—
0
0
7
32
2.19
1.08
1.3
1.2
—
—
—
0
0
158
1374
1.17
1.06
1.3
1.2
—
—
—
0
0
10
52
1.93
1.06
1.1
1.4
0.14
1.71
u/ml
—
10
52
6
121
0.49
1.05
1.0
1.1
—
—
—
0
0
5
22
2.28
1.03
7.2
10.0
4.42
4.98
kpa
—
5
22
63
501
1.27
1.03
1.8
2.2
0.00
1.37
estimate
0.50
19
183
105
884
1.20
1.03
5.2
5.4
0.17
0.14
%
0.09
30
207
29
205
1.42
1.01
5.5
3.6
19.03
27.04
mg/l
1.17
20
151
103
867
1.20
1.01
5.4
5.1
0.21
0.10
%
0.37
34
220
7
36
1.95
0.97
1.1
1.4
29.57
27.31
s
—
7
36
10
54
1.86
0.96
1.1
1.3
143.40
150.50
nmol/l
—
10
54
718
6874
1.10
0.96
3.4
3.5
—
8418.33
—
0
12
30
217
1.39
0.94
2.1
2.5
128.44
131.95
g/l
0.43
25
184
18
118
1.53
0.91
1.2
1.4
3.66
3.27
u/ml
—
10
72
133
1159
1.16
0.90
1.5
1.5
—
—
—
0
0
41
315
1.31
0.89
1.2
1.4
325.25
297.45
ug/g
0.43
24
184
103
880
1.19
0.88
1.4
1.5
21.20
23.09
iu/l
0.29
85
734
616
5875
1.09
0.87
4.1
3.6
0.00
0.28
estimate
0.53
112
1124
82
688
1.20
0.86
1.7
1.6
298.00
294.40
mu/l
0.05
73
619
28
204
1.38
0.85
4.1
3.1
—
—
—
0
0
76
634
1.21
0.85
1.8
2.2
3.67
8.40
ug/l
5.31
60
568
14
88
1.60
0.84
1.1
1.1
—
—
—
0
0
49
390
1.27
0.83
1.1
1.1
0.46
1.29
u/ml
1.23
21
194
159
1414
1.14
0.83
2.1
2.0
—
—
—
0
0
48
382
1.27
0.82
1.8
1.8
0.21
0.24
g/l
1.40
40
364
932
9560
0.91
0.81
6.2
5.4
38.77
38.17
mmol/mol
0.95
875
9121
294
2724
1.10
0.76
5.4
4.6
—
—
—
0
0
342
3656
0.91
0.76
1.6
1.7
—
—
—
0
0
101
875
1.17
0.76
8.4
9.2
8.22
8.21
mmol/l
0.01
96
843
11
68
1.62
0.71
2.1
3.6
874.09
740.49
u/ml
0.20
11
68
11
68
1.62
0.71
1.2
1.4
—
—
—
0
0
11
68
1.62
0.71
2.6
2.6
—
—
—
0
0
302
2812
1.10
0.71
1.5
1.5
2.45
2.19
g/l
0.91
173
1795
18
126
1.43
0.70
1.4
1.3
—
—
—
0
0
47
382
1.24
0.70
2.2
5.2
401.77
328.44
mg/l
0.18
22
199
30
230
1.31
0.70
1.3
1.2
—
—
—
0
0
301
2808
1.09
0.68
2.9
3.2
0.40
0.34
e6/l
0.33
234
2005
12
77
1.56
0.68
2.1
1.6
0.50
0.48
e9/l
0.11
12
77
45
365
1.24
0.68
1.4
1.3
—
—
—
0
0
5
27
1.86
0.68
3.4
3.4
13.60
6.07
ug/l
—
5
27
5
27
1.86
0.68
1.2
1.3
7.94
12.72
mmol/l
—
5
27
54
447
1.22
0.68
1.1
1.2
1.31
2.84
u/ml
1.04
28
253
99
866
1.16
0.67
3.8
2.2
6.37
6.16
ph
1.27
63
571
141
1264
1.13
0.67
2.7
3.6
4.96
7.30
umol/l
2.12
116
1094
40
494
0.80
0.66
1.4
1.5
1.14
1.27
mm
1.22
32
363
191
1746
1.11
0.66
2.4
2.9
1.38
0.89
e6/l
1.02
101
894
53
440
1.21
0.66
2.2
2.3
—
—
—
0
0
101
1146
0.87
0.66
1.4
1.6
1142.67
999.01
mu/l
0.59
87
973
18
128
1.41
0.66
1.4
1.3
2.62
2.78
g/l
0.22
13
96
18
128
1.41
0.66
1.4
1.3
0.34
0.36
g/l
0.15
13
97
18
128
1.41
0.66
1.4
1.3
6.93
6.32
g/l
0.45
13
98
26
337
0.77
0.64
1.2
1.1
—
—
—
0
0
26
336
0.77
0.63
1.2
1.1
—
—
—
0
0
40
324
1.24
0.63
1.2
1.2
—
—
—
0
0
48
397
1.22
0.62
1.8
1.7
1.14
1.19
g/l
0.44
40
378
298
2792
1.09
0.62
4.6
4.3
13.68
10.31
mg/mmol
0.37
195
1818
36
289
1.25
0.61
1.0
1.1
0.10
0.27
u/ml
0.67
11
103
0
20
0.00
0.60
0.0
1.1
—
27.00
—
0
5
0
20
0.00
0.60
0.0
1.1
—
17.40
—
0
5
20
148
1.36
0.60
2.0
2.3
—
—
—
0
0
293
2749
1.09
0.59
3.9
3.6
68.65
61.16
mg/l
0.19
200
1835
26
201
1.30
0.59
1.1
1.3
2.22
5.43
u/ml
—
9
92
11
72
1.53
0.59
1.3
1.3
—
—
—
0
0
462
4414
1.07
0.58
3.9
3.3
0.03
0.03
estimate
0.05
96
1000
0
23
0.00
0.58
0.0
1.6
—
—
—
0
0
88
774
1.15
0.58
1.3
1.2
—
—
—
0
0
42
506
0.82
0.57
1.4
1.5
—
—
—
0
0
37
301
1.24
0.57
1.1
1.1
6.09
7.14
u/ml
0.09
17
147
26
203
1.29
0.56
4.1
3.8
—
—
—
0
0
271
2545
1.08
0.54
2.5
2.7
323.20
333.09
umol/l
0.85
235
2314
103
921
1.13
0.54
1.4
1.3
163.61
237.64
u/ml
0.67
89
860
1148
11348
1.11
0.53
20.5
15.8
70.54
73.12
umol/l
1.53
1135
11234
86
762
1.14
0.52
2.4
3.7
4.52
4.69
pmol/l
0.89
75
692
599
5793
1.06
0.51
4.0
3.5
0.00
0.00
estimate
0.50
120
1176
969
9518
1.07
0.51
22.6
16.5
13.30
13.41
%
2.07
958
9413
9
65
1.39
0.50
1.7
1.7
—
—
—
0
0
14
101
1.39
0.49
1.8
2.9
1.48
1.36
g/24h
—
6
66
54
465
1.17
0.49
3.2
3.0
1.02
1.02
ratio
0.64
46
436
7
45
1.56
0.49
1.3
1.2
—
—
—
0
0
28
226
1.24
0.48
1.1
1.1
2.74
1.92
eliau/ml
0.36
12
100
59
513
1.16
0.48
2.6
2.3
—
—
—
0
0
7
47
1.49
0.47
1.0
1.1
45.71
47.38
iu/ml
—
7
47
133
1449
0.91
0.47
1.9
1.9
—
—
—
0
0
10
68
1.47
0.47
1.0
1.1
1841.30
1536.10
miu/ml
—
10
68
7
48
1.46
0.47
1.3
1.2
—
—
—
0
0
26
209
1.25
0.46
1.3
1.7
0.65
0.79
g/l
0.35
18
169
44
513
0.85
0.45
1.4
1.6
—
—
—
0
0
25
201
1.25
0.45
3.3
3.4
10.38
8.00
pmol/l
0.27
25
201
27
329
0.82
0.44
2.3
3.2
100.20
1432.50
u/ml
1.56
22
283
13
95
1.37
0.43
1.0
1.1
—
—
—
0
0
59
670
0.87
0.43
1.1
1.1
—
—
—
0
0
5
32
1.56
0.42
1.0
1.1
—
—
—
0
0
5
32
1.56
0.42
1.0
1.1
—
—
—
0
0
0
15
0.00
0.41
0.0
8.2
—
—
—
0
0
0
16
0.00
0.41
0.0
1.1
—
—
—
0
0
0
17
0.00
0.40
0.0
1.1
—
—
—
0
0
0
17
0.00
0.40
0.0
2.6
—
4546.24
—
0
17
58
655
0.88
0.40
1.4
1.5
65.85
61.21
ug/l
0.31
49
560
0
18
0.00
0.40
0.0
1.0
—
—
—
0
0
228
2159
1.07
0.38
1.3
1.3
19.44
25.51
iu/ml
0.51
66
634
45
392
1.15
0.38
1.2
1.1
3.18
2.11
u/ml
0.18
23
221
321
3077
1.06
0.37
4.0
3.6
0.00
0.01
estimate
1.34
107
1119
233
2215
1.06
0.36
2.6
2.7
8.94
6.55
e6/l
1.08
213
2003
5
78
0.64
0.35
1.4
1.1
—
—
—
0
0
5
79
0.63
0.35
1.2
1.4
187.80
173.67
pmol/l
—
5
79
202
2132
0.94
0.35
2.0
1.9
—
—
—
0
0
17
135
1.26
0.35
1.2
1.3
0.61
0.59
nmol/l
0.09
17
129
15
117
1.29
0.35
1.3
1.3
—
—
nmol/l
—
0
0
6
88
0.68
0.33
1.0
1.0
—
—
—
0
0
10
74
1.35
0.32
1.0
1.2
—
—
—
0
0
6
47
1.28
0.32
1.7
1.8
—
—
—
0
0
37
324
1.15
0.31
1.0
1.1
5.44
5.40
u/ml
0.00
20
175
17
138
1.23
0.30
3.7
4.0
6000.06
332.84
u/ml
0.45
17
129
13
102
1.28
0.30
1.2
1.3
1.86
1.42
nmol/l
0.94
13
93
7
56
1.25
0.29
1.6
1.1
—
—
—
0
0
347
3357
1.05
0.29
3.3
2.8
0.00
0.04
—
9
50
36
408
0.88
0.29
1.3
1.1
—
—
—
0
0
67
614
1.10
0.28
1.4
1.4
—
—
—
0
0
79
730
1.09
0.27
1.6
1.8
1.67
1.32
g/l
0.71
72
689
23
196
1.18
0.27
3.1
3.6
89.67
90.16
%
0.15
23
187
10
77
1.30
0.26
1.1
1.0
—
—
—
0
0
49
445
1.11
0.25
1.7
1.7
13.61
7.33
u/ml
—
10
114
12
96
1.25
0.24
1.0
1.1
118.50
108.91
pmol/l
0.22
12
96
974
9833
0.96
0.23
4.7
4.3
5.81
5.79
mmol/l
0.19
914
9222
58
535
1.09
0.22
1.2
1.6
8.60
8.19
u/l
0.09
46
421
5
42
1.19
0.21
4.4
2.2
24.20
28.98
%
—
5
42
0
11
0.00
0.21
0.0
1.8
—
263.09
—
0
11
0
11
0.00
0.21
0.0
3.6
—
100.82
—
0
11
0
10
0.00
0.21
0.0
1.3
—
—
—
0
0
0
10
0.00
0.21
0.0
1.1
—
5.37
—
0
10
33
296
1.12
0.21
5.2
8.4
—
—
—
0
0
5
43
1.16
0.21
1.0
1.7
0.00
0.00
estimate
—
5
43
0
13
0.00
0.21
0.0
1.3
—
—
—
0
0
6
50
1.20
0.19
2.5
1.4
131.00
102.41
ng/l
—
6
50
22
193
1.14
0.19
2.1
2.3
81.84
136.77
ug/min
0.37
13
118
33
298
1.11
0.19
1.3
1.6
—
—
—
0
0
20
228
0.88
0.19
1.2
1.2
—
—
—
0
0
10
81
1.24
0.18
2.1
1.9
—
—
—
0
0
13
109
1.19
0.18
1.3
1.6
601.68
1056.03
pmol/l
—
5
15
7
60
1.17
0.17
34.9
43.0
6.74
7.51
ug/l
—
7
53
22
247
0.89
0.17
2.1
1.8
—
—
—
0
0
24
215
1.12
0.16
1.8
2.1
—
22.80
—
0
5
39
360
1.09
0.16
1.7
2.2
2.34
3.99
iu/l
—
10
154
6
76
0.79
0.15
3.0
3.5
0.17
0.83
index
—
6
76
19
169
1.13
0.14
1.2
1.6
70.95
24.59
ng/l
0.46
19
169
10
118
0.85
0.14
1.2
1.1
—
—
—
0
0
335
3288
1.03
0.14
2.5
2.1
—
—
—
0
0
205
2001
1.03
0.13
1.3
1.3
3.13
9.88
u/ml
2.67
62
794
11
127
0.86
0.12
2.8
2.9
48.17
39.48
%
1.48
11
127
10
85
1.18
0.12
1.4
1.5
11.51
23.50
umol/l
—
10
79
19
172
1.11
0.11
1.1
1.2
—
—
—
0
0
31
289
1.07
0.11
1.1
1.1
14.85
14.87
au/ml
—
6
77
12
136
0.88
0.11
1.3
1.2
—
—
—
0
0
15
134
1.12
0.11
2.1
2.2
—
—
—
0
0
75
779
0.96
0.10
4.4
4.4
20.25
27.34
ug/l
0.20
60
629
5
46
1.09
0.09
4.0
3.7
—
—
—
0
0
5
47
1.06
0.09
1.4
2.7
—
—
—
0
0
338
3335
1.02
0.09
3.6
2.9
0.03
0.04
estimate
0.04
92
970
5
48
1.04
0.09
3.0
3.4
15.00
16.65
%
—
5
48
349
3445
1.02
0.09
2.3
2.4
—
—
—
0
0
11
97
1.14
0.09
1.7
2.1
34.27
33.06
pg
0.50
11
97
6
54
1.11
0.09
1.0
1.3
171.00
465.02
u/l
—
6
48
19
206
0.92
0.08
1.4
1.1
—
—
—
0
0
44
420
1.05
0.08
1.4
1.2
—
—
—
0
0
10
113
0.88
0.08
1.1
1.2
—
—
—
0
0
5
62
0.81
0.08
1.4
1.1
112.20
193.54
iu/ml
—
5
62
5
64
0.78
0.08
33.2
37.5
101.60
131.83
ug/l
—
5
53
435
4309
1.01
0.07
2.0
1.9
1.48
1.37
mmol/l
1.26
386
3793
61
589
1.04
0.07
1.4
1.3
261.91
244.77
miu/ml
0.16
32
285
16
174
0.92
0.07
1.1
1.7
—
—
—
0
0
16
174
0.92
0.07
1.1
1.7
—
—
—
0
0
16
174
0.92
0.07
1.1
1.7
—
—
—
0
0
16
174
0.92
0.07
1.1
1.7
—
—
—
0
0
8
75
1.07
0.07
3.5
2.4
—
—
—
0
0
8
76
1.05
0.07
1.1
1.1
—
—
—
0
0
30
284
1.06
0.07
1.3
1.6
103.83
142.76
au/ml
—
6
94
9
84
1.07
0.07
1.0
1.1
—
—
—
0
0
27
255
1.06
0.07
6.8
3.5
57.91
57.70
%
0.02
27
255
24
226
1.06
0.06
1.3
1.3
12.27
19.22
u/l
0.67
13
191
181
1783
1.02
0.06
2.1
2.8
98.23
104.59
ug/g
0.11
139
1447
12
109
1.10
0.06
1.2
1.3
—
—
—
0
0
98
1001
0.98
0.06
2.5
2.3
10.93
12.71
nmol/l
1.20
86
925
29
278
1.04
0.04
1.9
2.4
—
—
—
0
0
19
180
1.06
0.04
8.1
3.9
4.47
4.21
e9/l
0.15
19
180
34
349
0.97
0.02
1.4
1.5
284.38
220.33
u/ml
0.41
16
206
592
5904
1.01
0.02
3.4
3.3
119.51
94.02
ug/l
1.01
565
5618
17
163
1.04
0.01
1.0
1.1
—
—
—
0
0
90
893
1.01
0.01
4.2
3.4
—
—
—
0
0
11
108
1.02
0.00
1.1
1.2
—
—
—
0
0
54
544
0.99
0.00
1.0
1.1
—
—
—
0
0
29
288
1.01
0.00
2.0
2.9
5.81
7.09
umol/l
0.29
23
221
14
139
1.01
0.00
1.2
1.1
16.84
17.58
u/ml
—
7
54
17
169
1.01
0.00
1.2
1.3
—
—
—
0
0
502
5024
1.00
0.00
3.0
2.8
—
—
estimate
—
0
0
117
1175
1.00
0.00
1.3
1.4
—
—
—
0
0
11
105
1.05
0.00
2.9
2.7
—
—
—
0
0
0
6
0.00
0.00
0.0
1.7
—
0.57
—
0
6
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
0
6
0.00
0.00
0.0
8.0
—
—
—
0
0
0
7
0.00
-0.00
0.0
1.1
—
—
—
0
0
0
5
0.00
-0.00
0.0
2.8
—
0.56
—
0
5
0
7
0.00
-0.00
0.0
2.9
—
201.57
—
0
7
8
80
1.00
-0.00
1.3
1.2
—
—
—
0
0
0
5
0.00
-0.00
0.0
1.0
—
—
—
0
0
6
63
0.95
-0.00
1.0
1.0
8.00
9.33
mu/l
—
6
55
8
89
0.90
-0.00
1.0
1.6
9.61
11.35
umol/l
—
8
82
0
5
0.00
-0.00
0.0
1.0
—
—
—
0
0
0
5
0.00
-0.00
0.0
1.0
—
—
—
0
0
0
8
0.00
-0.00
0.0
1.0
—
168.25
—
0
8
0
8
0.00
-0.00
0.0
1.0
—
35.51
—
0
8
0
5
0.00
-0.00
0.0
1.0
—
—
—
0
0
0
5
0.00
-0.00
0.0
1.0
—
64.76
—
0
5
0
5
0.00
-0.00
0.0
1.0
—
—
—
0
0
0
5
0.00
-0.00
0.0
1.0
—
—
—
0
0
0
5
0.00
-0.00
0.0
1.0
—
35.54
—
0
5
0
5
0.00
-0.00
0.0
1.0
—
3.45
—
0
5

Mortality – FinRegistry

↥

This endpoint is excluded (different definition than used in FinnGen).

Relationships between endpoints

↥

Index endpoint: GE_MODE – Generalized epilepsy, mode (most common among epilepsy diagnosis)

GWS hits: 1

This endpoint is excluded (different definition than used in FinnGen).